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List of abbreviations and symbols* 
ADP 
AMP 
ATP 
CoASH 
DNP 
dpm 
EDTA 
g 
GDP 
GSH 
GTP 
Ki 
KM 
NAD+ 
NADH 
- Adenosine-5'-diphosphate 
- Adenosine-5'-monophosphate 
- Adenosine-5'-triphosphate 
- Coenzyme A (reduced) 
- 2,4-Dinitrophenol 
- Disintegrations per minute 
- Ethylenediamine tetraacetate 
- Relative centrifugal force 
- Guanosine-5'-diphosphate 
- Glutathione (reduced) 
- Guanosine-5'-triphosphate 
- Dissociation constant of inhibitor-enzyme complex 
- Michaelis constant 
- Nicotinamide-adenine dinucleotide (oxidized) 
- Nicotinamide-adenine dinucleotide (reduced) 
ll 
NADPH - Nicotinamide-adenine dinucleotide phosphate {reduced) 
Pi - Inorganic orthophosphate 
PPi - Inorganic pyrophosphate 
Q02 - Velocity of oxygen uptake (~1 0 2/h per mg protein) 
Qlo -Factor indicating the increase of reaction velocity 
when the temperature is elevated 10°. 
RCOOH - carboxylic acid 
S.D. - Standard deviation 
Tris - 2-Amino-2-hydroxymethyl-1,3-propanediol 
U - Unit of enzyme activity (conversion of one ~mole of 
substrate per minute) 
•For abbreviations and symbols used in this thesis, which 
are not mentioned in the above list, see: Suggestions and 
Instructions to Authors in Biochimica et Biophysiea Acta, 
Elsevier, Amsterdam, 1965. 
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List of enzymes* 
Number Systematic Name 
1.1.1.27 L-Lactate,NAD 
oxidoreductase 
1.1.1.35 L-3-Hydroxyacyl-CoA,NAD 
oxidoreductase 
1.1.1.37 L-Malate,NAD 
oxidoreductase 
1.2.4.1 Pyruvate:lipoate 
oxidoreductase 
(acceptor-acetylating) 
1.3.99.3 Acyl-CoA,(acceptor) 
oxidoreductase 
1.4.3.4 Monoamine:oxygen 
oxidoreductase 
( deamina ting) 
1.6.2.? Reduced-NADP:ferri-
cytochrome c 
oxidoreductase 
1.9.3.1 Ferrocytochrome c:oxygen 
oxidoreductase 
1.11.1.6 Hydrogen-peroxide: 
hydrogen-peroxide 
oxidoreductase 
2.3.1.16 Acyl-CoA,acetyl-CoA 
c-acyltransferase 
2.3.1.? Palmitoyl-CoA:carnitine 
a-palmitoyltransferase 
Trivial Name 
Lactate dehydrogenase 
3-Hydroxyacyl-CoA 
dehydrogenase 
Malate dehydrogenase 
Pyruvate dehydrogenase 
Acyl-CoA dehydrogenase 
Monoamine oxidase 
NADPH cytochrome c 
reductase 
Cytochrome c oxidase 
Catalase 
3-Ketoacyl-CoA thiolase 
carnitine 
palmitoyltransferase 
*The recommendations of the International Union of Bio-
chemistry, Enzyme Nomenclature~ Elsevier, A~sterdam, 1965, 
are followed where possible. 
LIST OF ENZYMES 
Number 
2.3.1.? 
2.7.1.1 
2.7.1.40 
2.7.3.2 
2.7.4.3 
2.7.7.16 
3.1.1.1 
3.1.1.8 
3.1.3.1 
3.1.3.2 
3.1.3.5 
3.1.3.9 
3.2.1.26 
3.2.1.31 
3.4.4.4 
3.4.4.16 
3.5.3.1 
Systematic: Name 
Acyl-CoA:monoglyceride 
a-acyl transferase 
ATP:D-hexose 6-phospho-
transferase 
ATP:pyruvate 
phosphotransferase 
ATP:creatine 
phosphotransferase 
ATP:AMP phospho-
transferase 
Ribonucleate pyrimidine-
nucleotido-2'-
transferase (cyclizing) 
Carboxylic-ester 
hydrolase 
Acylcholine 
acyl-hydrolase 
Orthophosphoric mono-
ester phosphohydrolase 
Orthophosphoric mono-
ester phosphohydrolase 
5'-Ribonucleotide 
phosphohydrolase 
D-Glucose-6-phosphate 
phosphohydrolase 
S-D-Fructofuranoside 
fructohydrolase 
S-O-Glucuronide 
glucuronohydrolase 
L-Arginine amidino-
hydrolase 
Trivial Name 
Monoglyceride 
acyl transferase 
Hexokinase 
Pyruvate kinase 
Creatine kinase 
Adenylate kinase 
Ribonuclease 
Carboxylesterase 
Cholinesterase 
Alkaline phosphatase 
Acid phosphatase 
5'-Nucleotidase 
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Glucose-6-phosphatase 
B-Fructofuranosidase 
(sucrase) 
B-Glucuronidase 
Trypsin 
Subtilopeptidase A 
(Nagarse) 
Arginase 
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Number 
3.5.4.4 
3.6.1.3 
4.1.3.6 
4.1.3.7 
5.3.1.9 
6.2.1.1 
6.2.1.2 
6.2.1.3 
6.2.1.? 
6.2.1.? 
Systematic Name 
Adenosine aminohydrolase 
ATP phosphohydrolase 
Citrate oxaloacetate-
lyase 
Citrate oxaloacetate-
lyase (CoA-acetylating) 
D-Glucose-6-phosphate 
ketal-isomerase 
Acetate:CoA ligase {AMP) 
Acid:CoA ligase (AMP) 
Acid:CoA ligase (AMP) 
Acid:CoA ligase (AMP) 
Acid:CoA ligase (GDP) 
LIST OF ENZYMES 
Trivial Name 
Adenosine deaminase 
ATPase 
Citrate lyase 
Citrate synthase 
Glucosephosphate 
isomerase (phospho-
glucose isomerase) 
Acetyl-CoA synthetase; 
short-chain acyl-CoA 
synthetase 
Octanoyl-CoA 
synthetase; medium-
chain acyl-CoA 
synthetase 
Palmitoyl-CoA 
synthetase; long-
chain acyl-CoA 
synthetase 
Lauroyl-CoA synthetase 
GTP-dependent acyl-CoA 
synthetase 
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CHAPTER l 
Introduction 
Reaction mechanism of palmitate conversion 
Palmitate, one of the important substrates to maintain 
life, is metabolically quite inert. However, it can be es-
terified with coenzyme A. In this activated form the acyl 
group can be used in various biochemical pathways, viz. ox-
idative degradation, the synthesis of esters {glycerides, 
phospholipids, cholesterol esters, waxes) and amides (glyco-
lipids) , or the formation of other fatty acids by elongation 
or desaturation of the carbon chain {Fig. l). 
The energy required for thioester formation is supplied 
1 2 by hydrolysis of ATP into AMP and PPi' (Eqn. l). The 
M 2+ 
:2.o:.... 
-.:::---
reaction is catalyzed by palmitoyl-CoA synthetase, also 
glycerides palmitate cis-palmitoleate 
phosphatides t 
"'- hydrolysis / 
esterifica~ I /aturation 
PALMITOYL- CoA /""' transport elongation 
/ ~-oxidation ~ 
~ l- palmitoyl-
carnitine acetyi-CoA 
stearate 
arachidate 
Fig. 1. Some routes of palmitoyl-CoA utilization. 
(l) 
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referred to as palmitate thiokinase or long-chain fatty acid 
activating enzyme. The systematic name is acid:CoA ligase 
(AMP), EC 6.2.1.3. Unless explicitly mentioned otherwise 
the name palmitoyl-CoA synthetase in this thesis refers to 
the ATP-dependent enzyme. 
For the reaction catalyzed by palrnitoyl-CoA synthetase 
it is doubtful whether an enzyme-bound acyladenylate is 
formed, as found for short- and medium-chain acyl-CoA syn-
3-7 thetases . Two forms of palmitoyl-CoA synthetase in rat 
liver rnicrosomes have been reported: an active and an inac-
tive state. Incubation with CoASH and ATP results in activa-
tion of the enzyme; inactivation is caused by incubation 
with palmitoyl-AMP in the absence of CoASH. A CoA-enzyme 
complex is postulated as the active form 8 . Similar activa-
tion of palmitoyl-CoA synthetase activity by CoASH and ATP 
may be concluded from experiments with a triglyceride syn-
thetase complex, isolated from hamster intestine 9 ~ 10 . An 
acyl-carrier protein is probably involved in fatty acid ac-
tivation in intestine and some microorganisms 10 , 11 . 
Organ distribution and properties of palmitoyl-CoA synthetase 
After the discovery of the palmitoyl-CoA synthetase in 
guinea-pig liver by KORNBERG AND PRICER1 (cf. ref. 12), re-
search has also been carried out on the enzyme in intestinal 
preparations from rat13 - 18 (Appendix, Paper 4), cat19 and 
guinea pig19 , adipose tissue from rat 20 - 24 and man 25 , and 
rat kidney 26 - 28 and heart16 ' 26 ' 28 ~ 29 (Appendix, Paper 4). 
High rates of long-chain acyl-CoA biosynthesis have been re-
ported in rat liver 8 ' 16 , 27 ~ 28 ' 30 - 39 .(Appendix, Papers 2 and 
4), which was originally found to contain rather low long-
chain acyl-CoA synthetase activity1 ~ 40 ~ 41 . TRZECIAK42 re-
ported palmitoyl-CoA synthetase activity in swine aortic 
43 
wall, whereas FARSTAD AND SANDER recently found long-chain 
acyl-CoA synthetase activity in human blood platelets. The 
organ distribution has been studied in the rat by PANDE AND 
MEAD 26 and by AAS 28 . 
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Palrnitoyl-CoA synthetase activity has also been demon-
strated in protists, in plants and in non-mammalian members 
of the animal kingdom. Long-chain acyl-CoA synthetase is 
found in Bacillus megaterium44 and Escherichia coli 45 - 48 , 
but not Clostridium butyricum49 . Candida tropicalis, a 
yeastlike organism, which can be grown on n-tetradecane, 
exhibits palrnitoyl-CoA synthetase activity 50 - 52 . Further-
more, the enzyme is found in mesocarp from avocado (Persea 
americana) 53 and in endosperm of castor bean (Ricinus com-
munis) 54-56. Long-chain acyl-CoA synthetase activity is 
present in eggs of the giant intestinal roundworm (Ascaris 
lumbricoides) 27 , in flight muscle of the southern armyworm 
moth (Prodenia eridania) 57 , and in skeletal muscle of the 
mackerel (Pneumatophorus diego) 58 • 
The organ distribution in mammals of palmitoyl-CoA 
synthetase26 ~ 28 , carnitine palmitoyltransferase 59 , 3-hydrox-
yacyl-CoA dehydrogenase 60 and 3-ketoacyl-CoA thiolase60 
roughly correlate. Liver is most active, followed by moder-
ate activity in heart and kidney, whereas lung, skeletal 
muscle and brain have little activity. The subcellular and 
submitochondrial localization of palmitoyl-CoA synthetase 
is discussed in Chapter 2. 
Microbiological studies suggest that the expression of 
the linked structural genes of the acyl-CoA synthetase form 
46~47 a regulon, which is controlled by a regulator gene 
There is some evidence that the (mammalian) palmitoyl-CoA 
synthetase could be regulated by a soluble protein kinase61 -
63 (contrast: ref. 2; see also ref. 64 for observations on 
the phosphorylation of medium-chain acyl-CoA synthetase) . 
Long-chain acyl-CoA synthetases have been (partially) 
purified from rat liver microsomes 2 ~ 8 , E. coli 48 and B. meg-
aterium44. The activity of the microsomal palmitoyl-CoA syn-
thetase is found to be quite unstable after purification 2 ~ 8 . 
The increase in specific activity is very low. The molecular 
weight is estimated to be 250,000. BAR-TANA et al. 2 stated 
that this value is presumably exaggerated owing to the pres-
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ence of unknown amounts of detergent bound to enzyme. The 
enzyme reacts with at least c 12 - c 18 saturated or unsatu-
rated fatty acids 2 . A rnultienzyme complex, purified about 80 
times from E. coli, has a molecular weight of 120,000 (ref. 
48). The latter enzyme is active with c 4 - c 18 fatty acids. 
Apparent KM's for palmltate2 ' 34 , ATP2 ' 34 and CoASH2 of re-
spectively 0.04 mM, 4 mM and 0.05 roM have been reported for 
the rat liver microsomal enzyme. The synthetase, demonstrat-
ed by KORNBERG AND PRICER1 in the microsomal fraction of 
guinea-pig liver, shows no significant variation of activity 
in the pH range from 6.5 to 8.0. The inner membrane enzyme 
of rat liver mitochondria has comparable properties (unpub-
lished observations). The purified palrnitoyl-CoA synthetase 
from rat liver microsomes exhibits a sharp optimum at pH 9 
(ref. 2), whereas the enzyme in rat gut microsomes has high-
est activity at pH 6.8- 7.6 
has been reported for the E. 
(ref. 13). A pH optimum of 8.5 
" . 46 c:o ~,- -z. enzyme . 
The reaction rate of the microsomal (guinea-pig liver) 
enzyme at 40° is 2 to 3 times as rapid as at 25° (ref. 1). 
A higher value is found for palmitoyl-CoA synthetase in rat 
liver and heart mitochondria 5 5 (Appendix, Paper 6). Stimu-
lation of the enzyme by high salt concentrations has been 
reported66 , 67 . 
GTP- dependent acyl- CoA synthetase 
An enzyme catalyzing acyl-CoA synthesis with GTP, ac-
cording to Eqn. 2, has been demonstrated in several tissues 
and isolated from beef liver and rat kidney and liver mito-
chondria by ROSSI et al. 68 - 79 . The enzyme is able to acti-
M 2+ 
RCOOH + GTP + CoASH ~ RCOSCoA + GDP + P. (2) 
-..::---- ~ 
vate palmitate, although the KM is quite high (2 - 3 mM). 
The substrate specificity of the synthetase is dependent on 
the isolation procedure. 4'-Phosphopantetheine is necessary 
for full activity. Pi and fluoride inhibit the isolated en-
zyme severely. The findings of the ROSSI group have not yet 
been confirmed by other laboratories, presumably due in part 
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to a difference in the rat strain used79 . No or very low 
palmitoyl-CoA synthetase activity with GTP substituted for 
ATP was found in B. megaterium44 E. coZi 46 , C. tropicalis 
rnitochondria51 • 52 , castor bean endosperm55 , 56 , moth flight-
muscle mitochondria 57 , bovine brain mitochondria80 , rat liv-
er26•35'81•82 (Appendix, Papers 2 and 5), heart 26 • 83 , kid-
ney26•83, intestine26 , adipose tissue23 • 24 • 26 • 84 and other 
rat organs 26 . Whether the GTP-dependent acyl-CoA synthetase 
is of physiological importance has been doubted 35 (Appendix, 
Paper 2). It may 1 however, play a r6le in the synthesis of 
intrarnitochondrial GTP. 
Scope of the present study 
In the past decade some work has been done on the sub-
cellular localization of palmitoyl-CoA synthetase in intes-
tine. However, marker enzymes (to characterize subcellular 
fractions) were sometimes applied in a wrong way 13 , 85 oro-
mitted from the investigation 26 . 
A number of schemes had been published concerning the 
(liver) mitochondrial compartmentation of enzymes involved 
86-93 in fatty acid breakdown . The presumed loci of ATP and 
GTP-dependent acyl-CoA synthetases were often derived from 
oxidation experiments with liver mitochondria in which use 
was made of inhibitors. These sometimes lacked the assumed 
specificity. When it was found, for instance, that atrac-
tylate94~95 and P. 35 ' 96 (Appendix, Papers 2 and 3) had more 
l 
effects than accounted for in the schemes, new investiga-
tions were desirable. 
A dearth of reports on myocardial palmitoyl-CoA synthe-
tase was observed. 
In the course of a study on the oxidation of ketone 
bodies an inhibitory effect of Pi' in the presence of DNP, 
was noticed (Chapter 3). Similar observations had been re-
ported in the literature for fatty acid oxidation. The ef-
fect had been ascribed to an inhibition of the GTP-
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dependent acyl-CoA synthetase (vide an~e). We were not suc-
cessful in demonstrating a GTP-dependent acetoacetyl-CoA 
synthetase in heart mitochondria. However, in our prepara-
tions GTP-dependent acyl-CoA synthetase activity was also 
very poor. When GTP was replaced by ATP high activities of 
the acyl-CoA synthetase were observed 35 {Appendix, Paper 
2). Because the GTP-dependent activation of fatty acids 
was found to be relatively unirnportant 1 we decided to re-
investigate the inhibition by Pi of fatty acid oxida-
tion35,96 (Appendix, Papers 2 and 3; Chapter 3). 
Considerations, mentioned above, started our research 
on aspects of the activity, regulation, and subcellular 
and submitochondrial localization in rat heart, liver and 
intestine. In the course of this investigation it became 
clear from studies by us 16 (Appendix, Paper 4) and independ-
ently by others 97 that Nagarse, a peptidase used to facili-
tate the isolation of muscle mitochondria, rather selec-
tively destroys palmitoyl-CoA synthetase activity (see 
Chapter 4). This finding was used in localization stud-
ies37'65'82 (Appendix, Papers 5 and 6; Chapter 2). The dis-
covery that adenosine is a strong inhibitor of palmitoyl-
CoA synthetase65 , 82 (Appendix, Papers 5 and 6) prompted a 
search for a possible r6le of this nucleoside in the regu-
lation of the activity of the enzyme (Chapter 5). 
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CHAPTER 2 
Localization of palmitoyl-CoA synthetase 
Subcellular localization 
Palmitoyl-CoA synthetase is partially soluble in pro-
caryotic cells44 , 46 , 48 ' 49 . In eucaryotic cells the enzyme is 
membrane bound28 ' 33 '3 4 ' 36 ' 3 8 . The "soluble" activity report-
ed in the older literature1 ' 41 ' 98 is probably due to incom-
plete sedimentation of microsomes. Palmitoyl-CoA synthetase 
activity is present in mitochondrial and microsomal frac-
tions. The available data are given in Table I. The quite 
large range of specific activities observed for liver and 
intestine may be due to: {i) hormonal and dietary condi-
tions102,103; (ii) differences in animal strain 79 and 
age 29 , 104 ; (iii) the lability of palrnitoyl-CoA synthetase 
(e.g. towards endogenous proteinases in the preparation12 
cf. Chapter 4); and/or (iv) different fractionation methods 
and activity determinations. To obtain high specific activi-
ties it is necessary to minimize the concentration of AMP 
(and adenosine formed through the s•-nucleotidase action in 
the preparation), e.g. by using an ATP regenerating sys-
tem16,36 (Appendix, Paper 4). Adenosine and also AMP inhibit 
6 5 82 . the palmitoyl-CoA synthetase ' (Appendlx, Papers 5 and 6; 
Chapter 5). 
In rat liver about the same specific activity is found 
in the mitochondrial fraction (58 mU/mg protein) and micro-
somal fraction (73 mU/rng protein) (average values of 11 - 15 
data reported by different authors, Table I). PANDE AND 
MEAD34 communicated the highest specific activity in the 
liver cell membrane fraction. We were not able to reproduce 
this finding (ref. 16; Appendix, Paper 4) with either the 
modified carnitine assay 16 ' 33 or the hydroxylamine method34 • 
Recently, also LIPPEL et az. 38 were unable to detect appre-
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TABLE I 
LONG-CHAIN ACYl-CoA SYNTHETASE ACTIVITY IN MITOG-IONDRIAL AND MICROSOMAL 
FRACTIONS 
Species Or>gan Mitochondria Micros ames Ref. 
Spec. act. Temp. Spec. act. Temv. 
(mU/mg) (0 c) (mU/mg) (o c) 
c. tropical. is 27 37 52 
Southern Flight 28 30 57 
armyworm moth muscle 
Rat Liver 17-135 37' 17-145 37* 2,8,16,28, 
30,32-38, 
81,95,97, 
99,100 
Rat Heart 27-37 37 38-60 37 16,26,28 
Rat Intes- ll-20 37 3-l19 37 13,15-17, 
tine*"'" 85 
Rat Skeletal 18 37 3 37 26 
muscle 
Rat Adipose 50-184 37 95-640 37 21,24,26 
tissue 
Rat Kidney 10 35 13 35 28 
Rat Brain 2 37 8 37 26 
Guinea pig Liver 1;10 37;40 12;1 
Guinea pig Intestine 20 37 19 
Rabbit Skeletal 8-23 37 58,97 
muscle 
Cat Intestine 54 37 19 
Pig Intestine 6 37 101 
Beef Heart 167 38 73 
*A Q10 of 3.0 was used to recalculate palmitoyl-CoA syn-
thetase activity if necessary 65 (Appendix, Paper 6). 
**The values of AILHAUD et az.85 were included. It was as-
sumed that rat intestine was used in their experiments. 
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ciable palmitoyl-CoA synthetase in this fraction. At least 
in liver, heart and gut there seems to be a correlation be-
tween the palmitoyl-CoA synthetase activity present in the 
mitochondrial or microsomal fraction and the function of 
the organ 16 (Appendix, Paper 4). [Attention is drawn to the 
relatively small amount of microsomal protein in heart tis-
sue105,106 (cf. ref. 16; Appendix, Paper 4).] A comparable 
conclusion was drawn for (rabbit) skeletal muscle by PANDE 
AND BLANCHAER58 , who found that the activity of palmitoyl-
CoA synthetase was twice as high in red as in white skeletal 
muscle. RODGERS AND BOCHENEK17 measured the activities of 
palmitoyl-CoA synthetase and monoglyceride acyltransferase 
in rat duodenum, jejunum and ileum. The enzyme activities 
were significantly greater in the proximal small bowel, 
which is thought to be the major site of lipid absorption. 
The high activity of palmitoyl-CoA synthetase in adipose 
tissue is interesting as this tissue has a profound capacity 
for triglyceride synthesis. Likewise the activity in moth 
flight muscle is noteworthy as carbohydrate is not used for 
flight energy in this species, but rather converted into lip-
id, which is stored as a low-weight high-caloric fue1 107 
In mesocarp from ripening avocado palmitoyl-CoA synthe-
tase is at least found in the microsomal fraction 53 , whereas 
long-chain 
located in 
acyl-CoA synthetase in 
54-56 the glyoxysomes . 
castor bean endosperm is 
It was reported earlier that no palmitoyl-CoA synthetase 
was present in the brush border fraction of rat intestine16 
(see Appendix, Paper 4). This correlates with recent find-
ings of SCHILLER et al. 108 , who do not find triglyceride 
synthetase activity in the brush border fraction from ham-
ster and rat gut. 
Intramitochondrial localization 
A number of studies have appeared in which the submi-
tochondrial loci of acyl-CoA synthetases are indicat-
ed81'91'109-111. As mentioned before newer findings made ad-
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ditional experiments desirable to gain insight in the local-
ization of acyl-CoA synthetases 100 ' 112 ~ The destructive ac-
. 16 82 97 tion of Nagarse on palm~toyl-CoA synthetase ' ' {Appen-
dix, Papers 4 and 5; Chapter 4) was used as a tool to elimi-
nate the very active hepatic outer membrane enzyme, which 
made earlier experiments difficult to interpreJ 1 ' 113 . Our 
oxidation experirnents 65 ' 82 (Appendix, Papers 5 and 6) and 
the fractionation studies of VANTOL AND HULSMAN~ 7 , both 
performed with Nagarse-treated rat liver mitochondria, indi-
cate that a palrnitoyl-CoA synthetase is present in the inner 
membrane plus matrix fraction. This finding is in agreement 
with the conclusion of SKREDE AND BREMER95 , who eliminated 
the outer membrane activity by oxidizing CoASH with tetra-
thionate. The activity of the inner membrane plus matrix en-
zyme is 5 - 10 % of the total liver mitochondrial palmitoyl-
CoA synthetase activity, which may be adequate to account 
for the oxygen uptake in the complete oxidation of palmitate. 
The contribution of the outer membrane palmitoyl-CoA synthe-
tase is indispensable when the rate of fatty acid consump-
tion is very high such as in ketogenesis37 . Moreover, the 
outer membrane enzyme may be required for phospholipid syn-
thesis114-116. 
Medium-chain acyl-CoA synthetases with broad specifici-
ty for fatty acids have been demonstrated in the inner mem-
brane plus matrix fraction 28 . The pH and temperature depen-
dence of palmitoyl-CoA and octanoyl-CoA synthesis in Nagarse-
treated liver mitochondria seem to be different (unpublished 
observations) , from which it could be concluded that the 
(inner membrane/matrix) medium-chain acyl-CoA synthetase is 
not involved in palmitate thioester formation (see, however, 
refs. 28 and 95). Possibly more information can be obtained 
by making use of differences in acyladenylate formation by 
substrate amounts of the two enzymes (see Chapter 1). 
In rat heart mitochondria only evidence is found for an 
outer membrane localized palmitoyl-CoA synthetase65 , 82 (Ap-
pendix, Papers 5 and 6). 
25 
CHAPTER 3 
The inhibition of fatty acid oxidation by phosphate 
In the course of an investigation of the oxidation of 
ketone bodies by heart mitochondria, it was noticed that P1 
inhibits the respiration in the presence of DNP. In Fig. 2 
the results of a manometric experiment are shown, in which 
rat heart mitochondria have been used to oxidize 3-hydroxy-
butyrate. After the addition of DNP, the presence of P1 in-
hibits the oxygen uptake. The same is observed when acetoac-
etate replaces 3-hydroxybutyrate (not shown) . A possible ex-
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Fig. 2. Influence of P1 on 3-hydroxybutyr:ttc oxidation by isolated rat hc<ll't mitochondria. Sarcosomcs 
were isolated in the presence of Nagarsc as described in ref. 16 (Appendix, Paper 4 ). Oxygen 
uptake was measured at 25° with differential manometers as described in ref. 117 (Appendix, Paper 1). 
The reaction medium contained 37.5 mM glucose, 25 mM KCl, 0. 5 mM EDTA, 5 mM MgCl2, 0.4 
mM DL-malate, 33 ).I.M cytochrome c, 0, 5 mM ATP, 25 mM sucrose, 75 mM Tris-HCl (pH 7. 6) and, 
where indicated, 37.5 m..\1 potassium phosphate (pH 7. 6) and/or 20 mM sodium DL~hydroxybutyra.te 
("3-0HBut" ). Vv'hcn Pi w:;..s included in the reaction medium the concentration of the Tris buffer W<lS 
reduced to 25 mM. In the blank 3-hydroxybutyrate and Pi were absent. The reactions were started by 
the addition of sarcosomes ( 1. 5 mg protein). After 7. 5 min the contents of the flasks were considered 
to be equilibrated. The taps were closed and readings were taken at 2. 5-min intervals. At the indicated 
time SO uJ DNP (in sucrose) was added from the side arm, giving a final volume of 1.0 mi. The final 
concentrations of DNP and sucrose were 50 ).I.M and 37.5 mM, respectively. 
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planation could be that the inhibition by Pi is due to a low-
ering of the steady state concentration of succinyl-CoA 118 ~ 119 
(see Eqn. 3), necessary for acetoacetate activation in 
heart 120 (Eqn. 4). In fact HATEFI AND FAKOUHI118 showed that 
succinyl-CoA is a potent activator of acetoacetate oxidation 
in beef heart mitochondria, even when 90 % of the oxygen up-
take is inhibited by Pi and AMP. 
succinyl-CoA + GDP + Pi ~ succinate + GTP + CoASH (3) 
acetoacetate + succinyl-CoA ~ acetoacetyl-CoA + succinate 
(4) 
That P. could inhibit the sarcosomal oxidation of ke-
1 
tone bodies in the presence of DNP, reminded us of a similar 
effect, discovered by VAN DEN BERGH91 ~ 109 • 121 , for fatty ac-
id oxidation in rat liver mitochondria. Here also, fatty ac-
id oxidation in the presence of DNP was inhibited by Pi. 
The dissimilarity between the main mechanisms of aceto-
acetate activation in heart sarcosomes, and the activation 
of fatty acid in liver mitochondria, made us wonder whether 
the inhibitory effect of Pi on fatty ac~d oxidation were in-
deed to be ascribed to inhibition of a GTP-dependent activa-
tion process 74 , 75 , 91 • 109 , 121 (see Chapter 1). We showed in 
polarographic experiments that the oxidation of pyruvate or 
other acetyl-CoA donors such as acylcarnitines, was also in-
hibited by Pi addition35 • 96 (Appendix, Papers 2 and 3). The 
inhibition of palmitoylcarnitine oxidation by Pi was confirm-
ed by HOFFMANN AND VAN DEN BERGH122 . Malate addition caused 
a relief of the Pi-induced inhibition of fatty acid, pyru-
vate or acylcarnitine oxidation35 • 96 (Appendix, Papers 2 and 
3). When P. was added after malate no inhibition was ob-
1 
served96 (Appendix, Paper 3). 
The GTP-dependent acyl-CoA synthetase is said to be in-
hibited by Pi and fluoride, the latter inhibition being prob-
ably diagnostic for the activation in intact mitochondria 75 . 
We do not consider this phenomenon to be diagnostic at all. 
Under the conditions used for the study of the GTP-dependent 
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acyl-CoA svnthetase, P. and fluoride also inhibit the oxida-
. ~ 
tion of pyruvate in intact rat liver mitochondria. The inhi-
bitions are completely relieved by the addition of malate a-
lone in the case of the Pi inhibition, and of malate plus P 1 
in the case of the fluoride inhibition (see Table II) . This 
indicates that an interruption of the citric acid cycle, re-
sulting in a deficiency of oxaloacetate, is the cause of the 
inhibition. P. addition causes a loss of citrate and malate 
. l . 9 6 from the m1tochondr1a (Appendix, Paper 3). This extrusion 
of citric acid cycle intermediates occurs presumably by an 
128 
exchange for P. (see refs. 125-127, and KLINGENBERG for a 
~ 
recent review on mitochondrial metabolite transport)-
H0LSMANN129 discovered that fluoride inhibits the oxi-
dation of 2-oxoglutarate in heart sarcosomes. The fluoride 
TABLE II 
Th.lHIBITION OF PYRUVATE OXIDATION BY INORGANIC PHOSPHATE AND FLUORIDE IN RAT LIVER 
MITOCHONDRIA 
Mitochondria were isobted ~described in ref. 16 (Appendix, Paper 4). Oxygen uptake was determined 
with differential manometers117 (Appendix, Paper 1). The medium consisted of 25 mM KCl, 5 mM 
MgCl2, 2 rnM EDTA, 40 mM Tris-HCl (pH 7.4), 75 mM sucrose, 0.1 mM DNP, 10 mM sodium pyru-
vate, 7. 5 mg mitochondrial protein ;J.nd, where indicated, 10 mM potassium (L)-malate, 15 mM KF 
;J.nd/or 15 mM potassium phosphate (pH 7. 4). For other conditions see legend to Fig. 2. After 53 min 
of incubation the reactions were stopped with HCl04 (final concentration 4%). The contents of the 
fl;J.sks were transferred to tubes, centrifuged and neutralized with KOH. KC104 was removed after stand-
ing in the cold and ;J.Cetoacet::r.te and 2-oxoglutarate were determined123, 124. 
Additions Without malate Plus malate 
-t;Oxygen* 62-0xo- -!;;Oxygen* t:.2-0xo-gZutaT>ate gZutaT>ate (flatoms) (flmoles) (J..Jatoms) (umoles) 
None 13 0. 1 17 0.2 
+ P. 5 
:!o 
0 .1 18 0.2 
+ F 4 0 .1 12 1.1 
-+ P. + F ~ 5 0.0 19 0.2 
""'Oxygen uptake was corrected for acetoaceta1:e formaL ion 
( 2 f-lat oms oxygen/f.lmole acetoace1:ate). 
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Fig. 3. Fluoride-induced 2-oxoglutarate accumulation in rat liver mitochondria, oxidizing pyruvate/ 
malate. Incubations were carried out in test tubes under agitation. 60 ID..t\1 Tris-HCI, 25 mM 
sucrose, 15 mM KF, 10 mM pot:lssium (L)-mal:lte and 6.0 mg mitochondrial protein were used. Other 
conditions were similar to those described in the legend to Table II (Pi w:lS omitted). After incubation 
for the times indicated in the figure, reactions were stopped by HCl04 addition. A=lysis for 2-oxo-
glut=te was performed on deprotcin:i<:cd, neutralized samples (see legend to Table II). 
inhibition of pyruvate oxidation is only partially relieved 
by malate alone, but completely by malate plus Pi (Table 
II). A possible explanation is the removal of Pi by fluo-
ride (magnesium fluorophosphate formation), resulting in 2-
oxoglutarate accumulation (Table II and Fig. 3) and oxalo-
acetate depletion. 
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CHAPTER 4 
Effect of Nagarse on palmitoyl-CoA synthetase 
Mitochondria isolated from different tissues differ in 
structure (shape, size, number of cristae) and functional 
properties 130 , 131 • By means of histochemistry and electron 
microscopy enzymatically and morphologically different mi-
tochondria have also been demonstrated in one tissue simul-
taneously130,132-135. Separation of mitochondrial species 
from each other has been achieved from liver, kidney, heart 
and skeletal rnuscle117 ' 130 , 133 - 139 (Appendix, Paper 1). 
From skeletal muscle of rat and man two types of mito-
chondria were isolated, one with loosely coupled oxidative 
phosphorylation localized probably subsarcolemmally, and an-
other, more "deeply localized" with tightly coupled oxida-
tive phosphorylation117 ' 136 (Appendix 1 Paper 1). Mild frag-
mentation of the muscle in a loose-fitting Potter-Elvehjem 
homogenizer preferentially released "subsarcolemmal" sar-
cosomes. By using a tight-fitting homogenizer and longer 
times to grind the tissue 1 more "deeply localized" mitochon-
dria were found in the preparation. H0LSMANN137 extended 
these findings to rat heart. He showed that it was possible 
by treatment with Nagarse* 1 a subtilopeptidase A 1 to release 
"deeply localized" mitochondria from heart muscle homage-
nates depleted from "subsarcolemmal" mitochondria. The lat-
ter had typical properties of tightly coupled mitochondria. 
After CHANCE AND HAGIHARA141 , 142 introduced the Nagarse di-
gestion of tissue to facilitate the isolation of mitochon-
*The nomenclature of the subtilisins, serine proteinases 
from strains of BacirZus subtiZis, has been changed several 
times. This has caused considerable confusion in the litera-
ture. Nagarse has been isolated from B. subtiZis strain N'. 
The synonyms subtilisin BPN' and subtilopeptidase C are used. 
All subtilisins belong to the category EC 3.4.4.16 with the 
recommended trivial name subtilopeptidase A (see ref. 140). 
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dria from pigeon and rat heart, the use of Nagarse for the 
isolation of sarcosomal fractions has almost become a stan-
dard procedure. Mitochondrial fractions were obtained from 
Nagarse-treated hearts of a variety of avian and mammalian 
species 143 - 158 , including man 157 . The method was also used 
for the isolation of mammalian skeletal muscle rnitochon-
dria58,145'156,159-162. The use of the proteinase gives mi-
tochondrial preparations (i) in an improved yield; (ii) with 
less contamination; and (iii) with improved integrity ac-
cording to the morphological and biochemical parameters 
tested. In oxidation studies mitochondria isolated with the 
Nagarse procedure showed oxidation rates (e.g. with pyruvate, 
succinate, 2-oxoglutarate and acylcarnitines) , P/0 and res-
piration-control ratios, which compared favorably with con-
ventially prepared mitochondria. Similar observations were 
made when trypsin was used in stead of Nagarse 156 , 163 
Although mitochondria isolated from Nagarse-treated 
heart and skeletal muscle homogenates would appear to be 
better than those isolated without the use of a peptidase, 
this conclusion is premature. It was found by LINDENMAYER 
et az. 164 that heart mitochondria prepared by the Nagarse 
procedure rapidly utilized NADH. They concluded that the 
permeability of a mitochondrial membrane is increased. BODE 
AND KLINGENBERG145 ' 165 - 167 and MAKINEN AND LEE 159 reported 
that mitochondria from heart and skeletal muscle are able 
to oxidize palmitoylcarnitine, but not palmitate. It was 
concluded that palmitoyl-CoA synthetase in these organs is 
absent {see also ref. 168). These sarcosomal preparations 
were obtained by the Nagarse method. FRITZ and cowork-
ers87'110 as well as ourselves 65 ' 82 (Appendix, Papers 5 and 
6) showed, however, that rat heart mitochondria {isolated 
without the proteinase) were able to oxidize palmitate (cf. 
ref. 169). PETER AND LEE 170 isolated mitochondria from rat 
skeletal muscle by a new, improved technique. These parti-
cles were able to oxidize palmitate as well. Rat skeletal 
muscle mitochondria, isolated by orthodox methods, e.g. as 
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described in ref. 117 (Appendix, Paper 1), exhibited similar 
properties (data not shown). By direct assay PANDE AND 
MEAD 26 , DEJONG AND H0LSMANN 16 (Appendix, Paper 4) and AAS 28 
demonstrated palrnitoyl-CoA synthetase activity in mitochon-
dria isolated from heart and skeletal muscle. 
It was found independently by PANDE AND BLANCHAER97 and 
ourselves16 (Appendix, Paper 4) that Nagarse destroys palrni-
toyl-CoA synthetase activity in heart, liver and skeletal 
muscle. Furthermore, it was shown by BLANCHAER and collabo-
rators (unpublished observations, see refs. 97 and 162) that 
Nagarse treatment of skeletal muscle mitochondria destroys 
the capacity to oxidize palmitate- We have made analogous 
observations for heart 65 , 82 (Appendix, Papers 5 and 6). Na-
garse treatment does not impair hepatic fatty acid oxida-
tion65'82 (Appendix, Papers 5 and 6), because in rat liver 
mitochondria palmitate can be activated also in the inner 
membrane plus matrix compartment, contrary to muscle (see 
Chapter 2). 
Palmitoyl-CoA synthetase in heart mitochondria is much 
less susceptible to Nagarse treatment when the proteinase is 
added to mitochondria oxidizing palmitate65 (Appendix, Paper 
6). Preincubation of mitochondrial sonicates of heart65 (Ap-
pendix, Paper 6) or liver (Fig. 4) with palmitate, ATP and 
CoASH protects the palmitoyl-CoA synthetase to some extent 
against proteolytic action. The protection seems to be more 
pronounced in the case of heart mitochondria. The stabiliz-
ing action of ATP on palmitoyl-CoA synthetase during the 
fractionation of cells, reported by AAS 28 , is possibly due 
to a similar effect. The presence of endogenous CoASH and 
palmitate together with added ATP may protect the enzyme a-
gainst endogenous proteinases. KORNBERG AND PRICER1 observed 
that their palmitoyl-CoA synthetase from guinea-pig liver 
microsomes was inactivated by 80 % by incubation with tryp-
sin at 40° for 30 min. 
Nagarse is reported to show a very wide substrate spec-
ificity171. The enzyme attacks about one third of the pep-
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tide bonds in casein and a quarter of those in gelatin. In 
addition, the enzyme hydrolyzes the ester bond172 ' 173 . RICH-
ARDS AND VITHAYATHIL 174 have used a subtilopeptidase A to 
split ribonuclease. It is quite surprising to read that in 
this case only one peptide bond is attacked, viz. between 
residues 20 and 21, without any loss of activity. Some spec-
ificity in inactivating action is also observed in our work 
with subcellular fractions. Monoamine oxidase, carnitine 
palmitoyltransferase, cytochrome c oxidase, carboxylesterase 
and glucose-6-phosphatase in isolated mitochondrial and mi-
crosomal fractions were relatively insensitive to Nagarse 
treatment16 ' 97 (Appendix, Paper 4). The activity of NADPH 
cytochrome a reductase disappeared from the microsomal frac-
- f 1 - 16 ( d" 4) h t1on a ter proteo ys1s Appen 1x, Paper . It was s own 
by TAKESUE AND OMURA175 that this was not due to inactiva-
tion, as the NADPH cytochrome c reductase was solubilized by 
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Fig. 4. ln~ctivation by Nagarse of p.almitoyl-CoA synthetase in a rat liver mitochondrial sonicate. 
Preincubation of 1. 0 mg mitochondrial protein was carried out in 0. 21 M sucrose JO. 01 M 
Tris-HCl (pH 7.4) at room temperature (220) for 5 min in a volume of 0. 24 ml. Where indicated 0. 25 
:mM potassium palmitate/0.03 :mM albumin, 1.2 mM ATP and 0.1 mM CoASH were added. The in-
dicated amounts of Nagarse were added in a volume of 10 f.J,l. Pro-rcolysis took place at room tempera-
ture for 5 min. Samples of 0.10 ml were assayed for palmitoyl-CoA synthetase activity with the [3H]-
camitine method16 (Appendix, Paper 4). Incubations were carried out at 37° for 6 min in a volume of 
I.Oml. 
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the proteinase. Inside the mitochondria enzymes are presuma-
bly protected by the outer membrane against proteolysis176 
However 1 also in ultrasonically or detergent disrupted mito-
chondria monoamine oxidase is perfectly able to resist Na-
garse attack, as is carnitine palrnitoyltransferase (experi-
177 
rnents not shown). Very recently, BOND compared the sus-
ceptibility of several soluble liver enzymes towards proteo-
lytic attack. She found that arginase activity was increased 
by treatment with subtilisin (Nagarse?). The arginase activ-
ity was then stable for the 2-h incubation period at 37°. 
Lactate dehydrogenase activity, on the contrary, decayed 
quite rapidly 177 . 
We conclude that the vulnerability of enzymes to the 
action of Nagarse depends on subcellular localization and 
enzyme structure. From the foregoing it is evident that the 
Nagarse method for the iso.lation of sarcosomes is not with-
out pitfalls. 
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CHAPTER 5 
The inhibition of palmitate activation by adenosine 
When the myocardial oxygen concentration diminishes (e. 
g. by hypoxia, a lower coronary blood flow or increased oxy-
gen consumption) breakdown of nucleotides to adenosine takes 
place178 - 180 . The mechanism of adenosine production from ATP 
by the myocardial cell is unknown181 During hypoxia cardiac 
blood flow is elevated presumably due to an adenosine-
induced vasodilatation182 - 184 . We considered the possibility 
that adenosine plays a r6le in the regulation of heart pal-
mitoyl-CoA synthetase activity. When the oxygen level in the 
heart is low, it makes no sense that mitochondria synthesize 
palmitoyl-CoA. It may even be dangerous. Because B-oxidation 
in the heart is impaired under these conditions, carbohy-
drate is catabolized to meet the energy requirements. Pal-
mitoyl-CoA is an effective detergent, which inhibits many 
enzymes in vitro 185 - 189 . Adenosine seems to be well-suited 
to control mitochondrial palmitoyl-CoA synthetase activity 
in vivo, because (i) quite low concentrations of adenosine 
inhibit the enzyme in mitochondrial sonicates; (ii) heart 
contains a large potential source of this nucleoside; (iii) 
it is formed in the heart under hypoxic conditions; and (iv) 
it is easy to get rid of the inhibitor, e.g. by deamination, 
phosphorylation or movement across the cellular membrane. 
In sonicates of rat heart mitochondria a K. of 0.1 mM 
' is observed for the adenosine inhibition of palmitoyl-CoA 
synthetase65 , 82 (Appendix, Papers 5 and 6). The inhibition 
is of the competitive type with respect to ATP. The speci-
ficity of the inhibition has been tested. The presence and 
the position of the amino group are important for the inhi-
bition: guanosine and inosine are much less potent inhibi-
tors65,82 (Appendix, Papers 5 and 6). Under the conditions, 
ADENOSINE INHIBITION 35 
specified in these references, !-methyl adenosine, 8-bromo-
adenosine, 6-mercapto guanosine, 6-deoxyguanosine, purine 
riboside, 6-mercapto purine riboside and 6-methyl aminopu-
rine-9-ribofuranoside inhibit less than 30 % (unpublished 
observations). Also the ribose moiety is necessary for the 
inhibition of palrnitoyl-CoA synthetase. Omission or modifi-
cation of the sugar by esterification usually results in 
loss of inhibitory power: adenine, 2'-deoxyadenosine and a-
denosine phosphates, including 3',5'-cyclic AMP (refs. 65 
and 82; Appendix, Papers 5 and 6), as well as 6-methyl ami-
nopurine, 2' ,3'-isopropylidene adenosine and 2' ,3'-diacetyl 
adenosine (unpublished results) are relatively poor inhibi-
tors. Only the pseudo nucleotide adenosine sulfate is as 
effective an inhibitor as adenosine65 (Appendix, Paper 6). 
Comparable results for the compounds mentioned above, were 
obtained on liver mitochondrial palmitoyl-CoA synthetase. 
It is concluded that the inhibition of heart mitochondrial 
palmitoyl-CoA synthetase by adenosine is quite specific. 
The next step of our research was on [
14
c]palmitate 
oxidation by isolated heart mitochondria. Adenosine (or a-
denosine sulfate) was able to inhibit oxygen uptake and 
14
co 2 production in these preparations
65 (Appendix, Paper 
6). Pyruvate oxidation, on the contrary, was not impaired 
on adenosine addition. 
Proceeding towards the in vivo situation we tested the 
effect of adenosine on palmitate metabolism in the isolated, 
perfused rat heart (Langendorf£ preparation). In control 
experiments it became clear that adenosine or dipyridamole* 
[2,6-bis-(diethanolarnino)-4,8-dipiperidinopyrimide (5,4-d) 
pyrimidine] caused an increase in flow rate of 2 - 4 times 
(Fig. 5). When dipyridamole is added together with adeno-
sine, results are obtained comparable to Expt. 1 (Fig. 5}. 
Dipyridamole (synonyms: Persantin, RA 8) is an inhibitor of 
adenosine deaminase193 . It is thought to augment the endog-
*Dipyridamole was a generous gift from Propharma, Haarlem. 
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Fig. 5. Influence of adenosine and dipyridamole on the flow rate of the isol:J.tcd, perfused rat heart. 
Fed male Wistar rats (220 - 280 g) were anesthetized v.'ith ;.;.bout 20 mg pentobarbital (Abbott) 
and heparinized with 500 I.U. Thromboliquinc (Organon). Langendorffprcparations, obtained as 
described by ZIMMERMAN erai.l90, 19l, were perfused at 370 with a Tyrodc solution, modified aC-
cording to MEIJLER191, 192, but containing 5 mM glucose. Usc was made of a pace maker, set .:tt 
5 pulses/sec, 2 msec duration and 0.2 mA. At the indicated points "the perfusion fluid was changed to 
Meijler's medium containing in addition: 0. 5 mM adenosine (Expt. I) or 0. OS mM dipyridamole (E.xpt. 
TI). In Expt. III the hc:lrt was perfused with dipyridJ.mole (0.05 mM) enriched medium J.nd Meijler's 
fluid ("norm:1l") J.ltcrn:ltcly. Expt. IV represents J. control in which no drug WJ.S J.ddcd. 
enous adenosine concentration through action on this deami-
nase193-196. Other evidence indicates that dipyridamole in-
hibits the transport of adenosine across the myocardial 
membrane 197 - 199 . If this were true under the conditions of 
Fig. 5, it should have had a negative effect on the flow 
rate in the experiment shown, since adenosine formed in the 
myocardial cells must penetrate to the blood capillaries in 
order to change the flow rate. The observations on the flow 
rate are in agreement with those done on the open-chest dog 
rnyocardiurn182 , 200 - 207 and the isolated, perfused heart of 
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the cat208 and the guinea pig182 
The application of the canula into the aorta takes 
1.5- 2 min. The heart is ischemic for this period. This 
causes accumulation of intracellular adenosine. The initial 
high flow rate is most probably due to endogenous adenosine 
that diffused across the cellular membrane. In further ex-
periments a period of 30 min was taken for perfusion with 
glucose medium (see legend to Fig. 5)- The height of con-
traction and the flow rate of the heart were usually con-
stant after this period .. Thenperfusion was started with a 
[ 14c]palrnitate/albumin containing medium in a recirculating 
system. Palmitate was removed from the perfusion fluid at a 
rate of 0.5 urnole/min per g myocardial protein (Table III). 
A comparable value was reported by RODIS et al. 212 . Higher 
rates of extraction were published by CRASS et al. 213 . The 
disappearance of [
14
c]palmitate from the perfusion fluid 
was stimulated twofold by the addition of 0.5 mM adenosine 
TABLE III 
EFFECT OF ADENOSINE ON PALMITATE EXTRA.CTION AND IA.CTATE ACCUMUlATION BY THE 
ISOLATED, PERFUSED RA.T HEA.RT 
Langendorf£ preparations were perfused as described in the legend to Fig. 5 for 30 min with Meijler's 
fluid, containing 5 mM glucose. Perfusion was continued in a recirculating sy.;tcm with SO ml Meijler's 
medium (5 mM glucose) fortified with 0. 5 mM [l- 14c]pal=itatc (0. 13 ).l.C /)J..molc)/0. 17 mM dialyzed 
bovine serum albumin, and, where indicated, 0. 5 mM adenosine. Foaming of this mixture, when 
equilibrated with 95%02/5% COz, was suppressed by application of a minimal amount of Antifoam A 
Spray (Dow Coming). The perfusion with palmitate/glucose medium took place for 30 rnin. Samples 
(0. 5 ml) were taken at 5~min intervals and analyzed for disappearance of radioactive label (corrected 
for 14cOz) and adenosinc209, and 1:he formation of lactatc2 10 and inosine211. Mean values arc given, 
with their S.D. where appropiate, whereas the number of experiments is given in brackets. 
-ll.[1jc Palmitate 
li.Lactate 
-li.Adenosine 
fl. Inosine 
(~mole/min per g myocardial protein) 
Minus adenosine 
0.47 + 0.10 (6) 
0.62 + 0.43 (4) 
Plus 
l. DO 
2.29 
l. 68 
adenosine 
+ 0.28 (6) 
+ 0.48 (6) 
+ 0.32 (S) 
l. 35 (3) 
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(Table III). Similarly, in the presence of dipyridamole or 
adenosine sulfate, which also caused an increase in flow 
rate, palmitate extraction was increased (not shown) . Pre-
liminary experiments indicate that also 14co2 production 
from palmitate is elevated, when adenosine is present in the 
perfusion fluid. Therefore, it seems doubtful whether the 
mitochondrial palmitoyl-CoA synthetase is inhibited by added 
nucleoside. Exogenous adenosine is unlikely to accumulate in 
the myocardial cell to a significant extent (cf. ref. 214). 
Adenosine dearninase is an active enzyme in heart 181 , 215 - 217 
(cf. inosine formation, Table III). Furthermore, adenosine 
kinase rapidly phosphorylates adenosine in cat heart208 , 218 
and rabbit heart219 . No net synthesis of adenine nucleotides 
under our conditions was observed (Table IV), but [s- 14c ]a-
denosine was incorporated in the nucleotides (experiment not 
shown, compare ref. 219). From the drop in creatine phos-
phate content of the heart, following adenosine administra-
tion (Table IV) , one could argue that transphosphorylation 
by the creatine kinase reaction is necessary to keep the ATP 
concentration at the control level. However, to support such 
a hypothesis, it would also be necessary to know the effect 
of adenosine on the myocardial creatine concentration. 
TABLE IV 
NUCLEOTIDES AND CREATINE PHOSPHATE IN RAT HEART AFTER ADENOSINE PERFUSION 
Langendorlf preparations -wes:e perfused as described in the legend to Table III. Mter 30 min of recircu-
lation hearts were clamped at liquid nitrogen temperature and deproteinized in the cold with HCl04 . 
In neutralized extracts ( c[. Table II) A TP220, ADP221, AMP221 and creatine phosphate222 were 
determined. 
umoles/ g myo~ardiaZ protein 
Minus adenosine Plus adenosine 
ATP 18.1 + 3.4 (5) 16.0 + 4.2 (7) 
ADP 4.2 + 1.1 (5) 4.5 + 1.2 (7) 
AMP 0.5 + 0.2 (5) 1.4 + 0.8 (7) 
EAdenine nucleotides 23.0 + 3.8 ( 5) 22.0 + 4.0 (7) 
Creatine phosphate 30.4 (2) 18.1 + 1.6 (4) 
ADENOSINE INHIBITION 39 
Recently, WIELAND et al. 223 observed with the isolated 
rat heart, perfused with a glucose-containing salt medium, 
that the addition of palmitate resulted in an augmented lac-
tate level. It is likely that a stimulation of fatty acid 
extraction by added adenosine could result in an elevated 
lactate concentration, as is shown in Table III. WIELAND et 
ar.
223
•
224 have presented evidence for their hypothesis that 
an increased supply of long-chain fatty acids is responsible 
for the conversion of active to inactive myocardial pyruvate 
dehydrogenase, resulting in lactate accumulation. 
Is adenosine involved in the regulation of cardiac fat-
ty acid metabolism in vivo? In the hypoxic rat heart tri-
glyceride synthesis is increased225 . Lipid accumulation in 
the heart also occurs in the clinical counterpart of myocar-
dial hypoxia: myocardial infarction226 . Obviously, adequate 
amounts of acyl-CoA can be generated for lipid synthesis un-
der these conditions, where adenosine production is increas-
ed. The findings in isolated sarcosomes on the adenosine in-
hibition of palmitate activation and oxidation, are possibly 
restricted to the in vitro situation. From our findings with 
the isolated, perfused heart and the data in the literature 
the conclusion might be drawn that adenosine has probably 
nothing to do with myocardial palmitoyl-CoA synthetase in 
vivo, because the myocardial concentration of the nucleoside 
is likely to be always far below the Ki for the inhibition 
of palmitate activation. More studies are required on the 
activity and compartmentation of enzymes involved in adeno-
sine and palmitate metabolism, before a definite statement, 
pertinent to the matter in question, can be made. 
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Summary 
1. The specific activity of palmitoyl-CoA synthetase 
(EC 6.1.2.3) in rat liver mitochondrial or microsomal frac-
tions is approximately 0.1 ~mole/min per mg protein (37°). 
2. In rat heart palmitoyl-CoA synthetase activity is 
mainly localized in the sarcosomal fraction, whereas in in-
testine the enzyme is predominantly localized in the micro-
somal fraction. 
3. There seems to be a correlation between the intra-
cellular localization of the activity of palmitoyl-CoA syn-
thetase and the function of an organ in lipid metabolism. 
4. From oxidation studies it is concluded that in rat 
heart sarcosomes the palmitoyl-CoA synthetase is localized 
on the outside of the outer membrane. In liver mitochondria 
an additional locus of palmitoyl-CoA synthesis with a spe-
cific activity of some 5 % of the overall mitochondrial pal-
mitoyl-CoA synthetase is present in the inner membrane plus 
matrix compartment. This activity can suffice for palmitate 
oxidation. 
5. Only 3 - 6 % of the activity of acyl-CoA synthetase 
is found when GTP replaces ATP. It seems doubtful whether 
the GTP-dependent acyl-CoA synthetase plays an important 
rOle in fatty acid activation. 
6. The inhibition by inorganic phosphate or fluoride 
can not be used to recognize the operation of a mitochondri-
al GTP-dependent acyl-CoA synthetase. Also pyruvate or acyl-
carnitine oxidation is inhibited by these agents. Phosphate 
addition causes extrusion of citric acid cycle intermediates 
from rat liver mitochondria. When pyruvate/malate is oxi-
dized in the presence of fluoride, 2-oxoglutarate accumula-
tion can be demonstrated. 
so SUMMARY 
7. Different species of mitochondria can be demonstrat-
ed in a single tissue. Separation from each other has been 
accomplished. The use of Nagarse (a subtilopeptidase A; EC 
3.4.4.16) in an isolation procedure doubles the yield of mi-
tochondria from muscle. On the basis of several biochemical 
parameters these mitochondria seem to be qualitatively bet-
ter than those obtained with conventional homogenization 
techniques. However, Nagarse destroys palmitoyl-CoA synthe-
tase activity. In sharp contrast, several marker enzymes for 
subcellular fractions do not loose their activity in the 
presence of the proteinase. When the substrates for fatty a-
cid activation are added, palmitoyl-CoA synthetase is less 
susceptible to the Nagarse action. 
8. The temperature dependence of rat liver and heart 
mitochondrial palmitoyl-CoA synthetase has been studied. A 
Q10 of 3 is found, which is quite high for an enzymatic re-
action. 
9. Adenosine inhibits palmitoyl-CoA synthetase activity 
in rat liver and heart mitochondrial sonicates. The nucleo-
side is a competitive inhibitor with respect to ATP with a 
Ki of 0.1 mM. The specificity of the inhibition is high. Of 
a variety of analogs only adenosine sulfate equals adenosine 
as an inhibitor. 2 mM Adenosine or 2 mM adenosine sulfate 
inhibit palmitate oxidation (in the presence of 2.5 mM ATP) 
in isolated rat heart mitochondria 60 - 90 %. 
10. The flow rate of the isolated, perfused rat heart 
increases fourfold, when the perfusion fluid is enriched 
with 0.5 rnM adenosine. Under these conditions the rate of 
palmitate extraction from the medium is doubled. It seems 
unlikely that the concentration of adenosine in the heart in 
vivo can be increased high enough to inhibit the palmitoyl-
CoA synthetase. 
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Samenvatting 
1. De specifieke activiteit van het palmitoyl-CoA syn-
thetase (EC 6.1.2.3) in gelsoleerde rattelever rnitochondrien 
of microsomen bedraagt ca. 0.1 ~mole/min per mg eiwit (37°). 
2. In rattehart is de activiteit van het palmitoyl-CoA 
synthetase overwegend gelocaliseerd in de sarcosomen, ter-
wijl het enzym in de darrn zich voornamelijk in de microsomen 
bevindt. 
3. Er lijkt een verband te bestaan tussen de activiteit 
van het palmitoyl-CoA synthetase in de verschillende celfrac-
ties en de functie van een bepaald orgaan ten aanzien van de 
stofwisseling van lipiden. 
4. Oxydatie-proeven wijzen uit dat in rattehart en -le-
ver mitochondrien het palmitoyl-CoA synthetase zich aan de 
buitenkant van het buitenmernbraan bevindt. In het binnenmem-
braan/matrix cornpartiment van lever mitochondrien bestaat een 
extra rnogelijkheid palmitoyl-CoA te maken. De specifieke ac-
tiviteit van dit tweede enzym bedraagt ca. 5 % van de waarde 
van de gehele mitochondriale palrnitaat activering. Deze acti-
viteit kan voldoende zijn voor palmitaat verbranding in lever. 
5. Slechts 3 - 6 % van de activiteit van het acyl-CoA 
synthetase resteert als ATP vervangen wordt door GTP. Het is 
twijfelachtig of het GTP-afhankelijke acyl-CoA synthetase van 
belang is voor de activering van vetzuren. 
6. De remming van de palmitaat oxyd~tie door anorganisch 
fosfaat of fluoride kan niet gebruikt worden voor het onder-
kennen van GTP-afhankelijke acyl-CoA synthetase activiteit in 
mitochondrien. De verbranding van pyruvaat of acylcarnitine 
wordt nl. ook gerernd door deze stoffen. Door toevoeging van 
fosfaat aan rattelever mitochondrien vindt uittreding plaats 
van interrnediairen van de citroenzuur cyclus. Als fluoride 
aanwezig is bij de verbranding van pyruvaat/rnalaat, hoopt 
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zich 2-ketoglutaraat op. 
7. In een weefsel kunnen verschillende soorten mitochon-
drien aangetoond worden, die van elkaar gescheiden kunnen 
worden. Door Nagarse (een subtilopeptidase A; EC 3.4.4.16) 
tijdens de isolatie te gebruiken, verdubbelt de opbrengst aan 
rnitochondrien uit spier. Te oordelen naar diverse biochemi-
sche parameters schijnen deze rnitochondrien kwalitatief beter 
te zijn dan rnitochondrien die geisoleerd zijn rn.b.v. conven-
tionele technieken. Het is echter zo dat Nagarse de activi-
teit van het palrnitoyl-CoA synthetase vernietigt. In schrille 
tegenstelling daarmee verliezen een aantal "gids" enzymen, 
gebruikt om subcellulaire fracties te karakteriseren, hun ac-
tiviteit niet als ze in aanraking zijn met het proteinase. 
Als het palmitoyl-CoA synthetas_e voorzien is van zijn sub-
straten, is het minder gevoelig voor de inwerking van het 
Nagarse. 
8. Het palmitoyl-CoA synthetase in rattelever en -hart 
mitochondrien blijkt een (betrekkelijk hoge) Q10 van 3 te 
hebben. 
9. Adenosine remt de palmitoyl-CoA synthetase activiteit 
in sonicaten_ van lever en hart mitochondrien. Het nucleoside 
remt competitief met betrekking tot ATP. De Ki is 0.1 roM. De 
specificiteit van de remrning is hoog: van een groot aantal 
analoga van adenosine blijkt alleen adenosine sulfaat even 
geed te rernmen als dit nucleoside. De palmitaat oxydatie door 
gelsoleerde rattehart mitochondrien, in aanwezigheid van 2,5 
mM ATP, wordt door 2 mM adenosine of 2 rnM adenosine sulfaat 
60 - 90 % geremd. 
10. De perfusiesnelheid van het geisoleerde, doorstroom-
de rattehart neemt een factor vier toe als 0.5 mM adenosine 
aan het medium wordt toegevoegd. Palrnitaat wordt onder deze 
ornstandigheden tweernaal zo snel door het hart uit het medium 
geextraheerd. Het lijkt onwaarschijnlijk, dat de concentratie 
van adenosine in het hart in vivo dusdanig kan oplopen dat 
het palmitoyl-CoA synthetase geremd wordt-
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Mitochondria with loosely and tightly coupled oxidative phosphorylation in 
skeletal muscle 
From skeletal muscle of humans, suffering from muscle disease, mitochondria 
can be isolated which sometimes show loosely coupled oxidative phosphorylation, 
although the patients do not show increased basic metabolic rates1 •2 • Tnis led us to 
conclude that our procedure of isolating mitochondria causes selection of loosely 
coupled mitochondria from a mixture of loosely aud tightly coupled mitochondria, 
present in diseased muscle. The subsarcolemmal space of the affected muscle fibres 
shows the most pronounced morphological changes1 •2• \i'\Fe concluded therefore that 
mild fragmentation of the muscle preferentially releases subsarcolemmal mito-
chond._'"ia. 
The present paper shows that skeletal muscle from non-diseased white rats, 
on mild fragmentation, also preferentially releases mitochondria with a more loosely 
coupled state of oxidative phosphorylation when compared to the mitochondria 
released after more thorough homogenization of the muscle. 
Mitochondria were isolated from 3 g of masseter muscle of rats. Tne muscles 
were chopped in two perpendicular directions with a Mcilwain tissue slicer {o.r mm 
distance between the cuts). The mince was then evenly suspended, by cutting with 
a pair of scissors, in 30 ml of isolation medium (pH 7-4), containing: 50 mM Tris-HCl, 
IOO mM KCi, 5 mM MgCI2• I mM ATP, I mM EDTA and 0.5 mg of bovine serum 
albumin per m1. The mince was stirred for 5 min and part of the mince homogenized 
TABLE I 
OXIDATIVE PHOSPHORYLATION OF SKELETAL MUSCLE MITOCHONDRIA 
The isolation of the mitochondria is described in the text. Oxygen uptake was measured with 
differential manometers. The reaction medium contained 25 roM glucose, 0.03 :ml\1 cytochrome c, 
o.r rn.M: L-ma1atc, 2.5 roM MgCl2 , 20 rnM potassium phosphate buffer, 0.5 mM ATP, 0.5 roM EDTA, 
so roM KCl, 25 mM Tris-HCl buffer, 0.75 mg bovine serum albumin, about I mg of mitochondrial 
protein, and 15 mM glutamate (Expt. I) or IS mM pyruvate (Expt. 2). The centre well of the 
manometer vessels was provided with KOH and a filter paper. The side arm of the flasks contained 
1.4 units (,umolesjmin) of hexokinase (EC 2.7.I.I). The reaction volume was I ml, the temperature 
25° and the pH 7-5· Readings were taken at regular intervals. After zo-24 min hexokinase was 
added from the side arm and after 20 min the reaction was stopped by the addition of perchloric 
acid (final concn. 4 %). The measurement of oxygen uptake and of phosphorylation, the calculation 
of the P/0 ratio and the respiratory control index (RCI) were carried out as described before1 , 
except that phosphoglucose isomerase (EC 5-3-L9) was included in the glucose-6-phosphate assay. 
Acid phosphatase activity was determined as described in ref. 3· 
Expt. Type of Qo, RCI P/0 Yield of Relative acid 
No. homogeni::er (+ hexo- heavy mitochondria phosphatase 
used kinase) (mg proteinfg muscle, activity y 
wet wt.) 
Loose 65 3·3 2.5 r.6 0.37 
Tight 87 5·4 2.6 2-5 0.24 
2 Loose g8 2.6 2.6 3·4 0.20 
Tight 135 4·5 2.7 6-7 O.Il 
• For deftnition and unit see text. 
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in a loose-fitting homogenizer (5 strokes in a Potter-Eivehjem type homogenizer with 
a 'Teflon' pestle and a ciearance of 0.25 mm (Expt. r) or 3 strokes in an all glass 
homogenizer with a clearance of o.r5 mm (Expt. 2) and another part of the mince 
homogenized (5 strokes in Expt. I; zo strokes in Expt. z) i>'l a tight 'Teflon' -glass 
homogenizer (clearance, o.ro mm). Particles sedimenting between 6oo X g (3 min) 
anci 4500 X g (ro min) were isolated by difierential centrifugation and suspended in 
the complete isolation medium. Ail operations were carried out at o-4 o _ 
It can be seen from the experiments shown in Table I that the use of a tighter 
homogenizer not only improves the :yield of the isolated muscle mitochondria, but 
also their quality, when a high respiratory control index may be used as a criterion 
for the intactness of the function of mitochondria. The release of the small amount 
of mitochondria by the use of the loose-fitting homogenizer was accompanied by the 
release of practically all of the ,8-glucuronidase (EC 3.2.I.3I) and acid phosphatase 
(EC 3-L3.2) activities from the minced muscle. The latter is reflected (Table I) by 
the relative acid. phosphatase activity, defined as the total activity (in units) in the 
6oo x g supernatant divided by the amount of mitochondrial protein (in mg) isolated 
from the 6oo x g supernatant_ Since lysosomes are most concentrated in the peri-
nuclear (subsarcolemmal) region, these findings indicate that mild fragmentation of 
muscle predominantly releases subsarcolemmal mitochondria. 
Whether these mitochondria have a more loosely coupled oxidative phospho-
rylation due to aging~, a process to which lysosomal activity could contribute5, or 
whether the tightness of the coupling of oxidative phosphorylation is another differ-
ence between the various types of skeletal muscle mitochondria which can be dis-
tinguished (cf- ref_ 6), still remains to be investigated. 
Finally it may be of interest to note that ScHMALBRUCH7 recently published 
that fibers of human lary"Tix muscles show lateral dilatations of the sarcolemma, con-
taining loosely disposed nuclei, lysosomes, lipofuscingranules and mitochondria, often 
with cristae arranged concentrically. 
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On fatty acid activation in rat liver mitochondria 
Two systems for the activation of fatty acids in liver mitochondria have been 
described, one catalyzed by ATP-dependent fatty-acid-activating enzymes' (acid: 
CoA ligase (AMP), EC 6.z.r.2 and EC 6.2.r.3) and a GTP-linked fatty-acid-activating 
system, discovered by Rossi AND GIBSON2. 
The purpose of the present investigation was to evaluate the relative contribu-
tions of the hvo fatty-acid-activating systems. Rat liver mitochondria, isolated in 
0.25 M sucrose, were suspended in o.I M Tris-HCl (pH 7.4), containing 2 mM reduced 
glutathione and I mM EDTA, prior to sonication for 6o sec at 3 A (Branson, Model 
S75) aro-4°. The sonicate was centrifuged for IO minat9500 XI(, and the pellet was dis-
carded. The supernatant was passed through a Sephadex G-25 column eqnilibrated with 
o.I M KCl before being tested for its ability to activate pahnitate, oleate or octanoate. 
Fig. 1. :A.utoradiograpbic demonstration of-paln.ltate activation. The reaction medium contained 
roo mM Tris-HCL, 0.25 mM [r-14C]palmitic acid (specific activity, 0.2 ~tC/~tmole) complexed 
with o.o35 mM bovine serom albumin, 3 /tg oligomycin, ro mM DL-carnitine, o.s mM CoA, 2 mM 
MgClz, 30 mM KCI. 0.32 mg of purified palmitoyl-CoA:carnitine palmitoyltransferase and o.2 mg 
of mitochondrial protein. The enzyme fractions were prepared as described in the text. Additions 
were in (2)2 mMGTP and in (3) 2 mM ATP. The reaction volume was I ml, the temperature 37°, 
and the pH 7-4· After ro min· of incubation the reaction was stopped with HCl and the incubation 
medium extracted with n-butanol, as described by FARSTAD, BREMER AND NORUM3• 0.05 ml of 
each-extract was applied to a thin-layer plate (silica gel). The chromatogram was developed with 
chloroform-methanol-~ter (70:30:5, vfvfv). Reference samples of [14C]palmitate, [14C]palmi-
toylcarnitine and [14C]palmitoyl-CoA were chromatographed in the same way (not shown), in-
dicating that the thick spots at the upper end of th~ autoradiogram are palmitate, those indic~ted 
by the arrow palmitoylcarnitine, and those just above the starting points palmitoyl-CoA. Agfa-
Gevaert-Osray :film was used (exposu~ time, 17 h). 
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The acyl-CoA formed was trapped as acylcarnitine by acyl-CoA: carnitine 
transferase, which is present in the sonicate. Addition of puriJied pahnitoyl-CoA: 
carnitine palmitoyltransferase, prepared as described by FARSTAD et al.', enhanced the 
amount of acylcarnitine formed by about so%, so that it was added routinely. 
It can be seen from Fig. r that the addition of GTP or ATP is required to 
activate palmitic acid, as judged by the formation of ["C]pahnitoyl-CoA and ["C]-
palmitoylcarnitine, detected by autoradiography of thin-layer chromatograms. It can 
also be seen that ATP is a much more efficient source of energy than GTP. By 
scraping the radioactive materials from the thin-layer plates and measuring the radio-
activity by liquid scintillation spectrophotometry, it was calculated that the specific 
activity (,umolesjmg protein per h) of the ATP-dependent reaction was 2.9 and that 
of the GTP-dependent reaction was o.r. 
When in other experiments palmitate was replaced by octanoate or oleate, the 
"GTP-system" had 3-6% of the activity of the "ATP-system". 
Reports from the literature'•', on the other hand, suggested to us that in intact 
liver mitochondria, the "GTP-system" is about as active as the "ATP-system". In 
these studies fatty acids are oxidized by intact rat liver mitochondria in the presence 
of dinitrophenol and the absence of (inhibitory) P,. The addition of dinitrophenol is 
required to stimulate the citric acid cycle by which, via oxidation of o:-oxoglutarate, 
GTP can be generated. Under these conditions ATP is also formed'. Moreover the 
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Fig. 2. Palmitate, palmitoylcarnitine and pyruvate oxidation, as measured with the Clark "oxygen 
electrode". The reaction medium contained 32 mM KCl, 4·5 mM MgCl2 , 73 m}.:[ Tris-HCl, I mM 
EDTA, 0.1 _mM dinitrophenol, 12 mM sucrose and 4·4 mg of mitochondrial protein. 0.12 mM 
palmitic acid complexed with 0.015 mM bovine serum albumin, 0.24 mM DL-palmitoylcarnitine 
and 5 mM pyruvate were added as indicated in Expts. A, Band C, respectively. Other additions 
were, where indicated, 17 mM potassium phosphate and 4-5 mM DL-malate. The reaction volume 
was. 2-.2 ml, the temp&ature 37°, and- the pH 7-5· 
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ADP present in the reaction medium' contributes to the formation of ATP through 
the myokinase reaction 6 • 
In the presence of dinitrophenol then, the "ATP-system'' for fatty acid activa-
tion might still operate in addition to the "GTP-system". The inhibition of fatty acid 
oxidation by Pi in the presence of dinitrophenol, used "as an argument in favor of the 
operation of the GTP-dependent fatty acid activation4 •.s in intact mitochonclria, will 
therefore be analyzed further. 
It can be seen from Fig. zA that we can confum the inhibitory action of P[ on 
palmitate oxidation in the presence of dinitrophenol. It may also be noted, however, 
that malate partially relieves the inhibition. This indicated to us that P1 at least 
partially inhibits the citric acid cycle. In agreement with this interpretation is the 
observation that substrates which do not need activation prior to oxidation, such as 
palmitoylcarnitine (Fig. zB) or pyruvate (Fig. zC), also show PI-inhibited respiration. 
which can be overcome by malate. 
It may be concluded, then, that Pi inhibition of fatty acid. oxidation does not 
necessarily mean the operation of the GTP-d.ependent fatty-acid-activation system 
in intact mitochondria. 
W"' e do not conclude from our data obtained. with sonicated mitochoncL.'"ia 
(Fig. I) that L'le "GTP-system" does not contribute significantly to fatty acid activa-
tion1 since preferential inactivation of the '"GTP-system" dlli-ing isolation cannot be 
excluded. The «ATP-system", however, is so active {z.g ,umoles/rng protein per h) 
that in intact mitochondria, palmitate oxidation with a Qo2 of 1478 could be expected 
if the activation .re~c±iOn w~re rate limiting (in practice we never found Qo-:.'s for 
palmitoylcamitine oxidation exceeding ISO). 
Future experiments "Will. be required to elucidate the role of substrate-linked 
~•·· ,--phosphorylation in fatty acid oxidation. 
: Vl e wish to acknowledge the expert technical assistance of Miss C. KALKMAN 
and Miss A-. C. VAN W AAS. 
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Phosphate-induced loss of citric acid cycle intermediates from rat-liver 
mitochondria 
In previous reports'·' it was shown that the inhibition by P 1 of palmitate 
oxidation by rat-liver mitochondria in the presence of 2,4-dinitrophenol is not specific 
for fatty acid oxidation. The oxidation of acylcarnitine and pyruvate is also impaired 
when P1 is present (Fig. rA and ref. r). If malate was added no inhibition could be 
observed. VAl\' DEN BERGH3 earlier observed that malate prevents to some extent the 
inhibitory action of P 1 on fatty acid oxidation by rat-liver mitochondria in the pres-
ence of 2,4-d.initrophenol. 
The inhibition by P 1 of fatty acid oxidation has been interpreted4• 5 as being 
diagnostic for the operation of the GTP pathway of fatty acid activation. However, 
from the results of our experiments we suggested that the P, inhibition could be due 
to the removal, under the influence of P1, of citric acid cycle intermediates from the 
mitochondria. 
Such a Prinduced removal would be expected to occur if P1 addition would 
allow the synthesis of phosphoenolpyruvate from oxaloacetate and GTP'. However, 
phosphoenolpyruvate formation in rat-liver mitochondria under the conditions of the 
assay is rather sluggish', whereas P 1 inhibition of pyruvate, acylcarnitine or fatty 
_acid oxidation sets in rapidly1. Moreover, when Pt is replaced by arsenate, during 
pyruvate oxidation, an inhibition is also observed, which can be overcome by malate 
addition (Fig. rB). From these considerations the rapid loss of citric acid cycle inter-
mediates by the formation of phosphoenolpyruvate becomes an unattractive hypo-
thesis. Alternatively, the results obtained could be explained by an exchange of citric 
acid cycle intermediates with P, (see refs. 7 and 8). 
In the experiment of Table I, rat-liver mitochondria were incubated in the 
presence of 2,4-dinitrophenol, with or without pyruvate and P,. The amounts of 
citrate and malate inside and outside the mitochondria were determined after 55 sec. 
The presence of P1 in the reaction mixture brought about an increase in the amount of 
citrate and malate outside the mitochondria. The total amount of citrate plus malate 
t i orsencrte 
t 
"'"""' ,_,. 
[o2J. o 
Fig. I. The effect of P1. arsenate and malate on pyruvate oxidation in the presence of 2,4-dinitro-
phenol in rat-liver mitochondria. Oxygen uptake was measured with the Clark "oxygen elec-
trode" at 37°. The reaction medium contained o.r mM 2,4-dinitrophenol, 29 mM KCI, 4.8 mM 
MgCI2 , 77 mM Tris-HCl (pH 7·4) and r mM EDTA. Rat-liver mitochondria (r.6 mg protein), 
2.4 m.i\{ sodium pyruvate, I4 mM potassium phosphate (Expt. A) or potassium arsenate (Expt. B), 
and 2.4 mM L-malate were added as indicated. The final volume wa:s 2.I mi. 
Biochim. Biophys. Acta, r84 (rg6g) 664-666 
SHORT COMMUNICATIO~S 
was higher in the presence of P 1 than in its absence, indicating withdrawal of these 
substances from intramitochondrial reactions. The fact that no malate could be 
detected in the mitochondria even in the absence of P1 indicates that it is rapidly 
converted to other tricarboxylic acid cycle intermediates when oxidation is allowed 
to occur. In freshly prepared, anaerobic mitochondria, considerable amonnts of malate 
are present. 
The inhibition by P1 of pyruvate oxidation can also occur in the absence of 
2 ,4-dinitrophenol, if the P 1 concentration is increased beyond that necessary for 
State 3 oxidation. Fig. 2 shows that increasing the P 1 concentration from r to r8 mM 
resulted in a 25% inhibition of pyruvate oxidation. On the contrary when I mM 
L-malate was present from the beginning, the inhibitory action of excess Pr on 
TABLE I 
LOSS OF CITRATE AND MALATE FROM RAT-LIVER MITOCHONDRIA ON THE ADDITION" OF P1 
Rat-livermitochondria(5.4 mgprotein) were incubated at37° in the reaction medium mentioned in 
Fig. r. Also present were 2.omM sucrose, and, where indicated, 2.4mM sodium pyruvate and r6mM 
P 1• Thefi.nalvolumewas r.zzml. Aftersssec, o.Smlofthe incubation medium was layered on silicon 
oil9 (v.rhich floated on I5% HCl04 ) and was centrifuged for I min at full speed in an Eppendorf 
"microfuge". 0.5 ml of the supernatant was immediately deproteinized. Citrate was detennined 
with citrate lyase, NADH and malate dehydrogenase (cf. ref. Io), and malate with malate dehydro-
genase, NAD+, citrate synthase (see ref. II) and acetyl-CoA, using the Chance-Aminco dual 
wavelength spectrophotometer. 
Additions 
None 
p, 
Pyruvate 
P).Tuvate + Pi 
0 
pyruvate"" 
malate 
nmolcsfmg protein 
Citrate 
in 
0.] 
0.2 
o.g 
0.2 
0 
Citrate 
out 
I.3 
4·2 
3-7 
8.8 
pyruvate 
[";) Cm><l 
lVl alate Malate 
in out 
0.0 I.] 
0.0 3-7 
0.0 o.g 
0.0 I.] 
Fig. 2. Effect of P 1 on pyruvate oxidation in coupled rat-liver mitochondria. Conditions as in 
Fig. I, except that o.S5 mg mitochondrial protein was present. In addition.. 1.2 mM ADP. and, 
where shown in the figure, L-malate (r mM) and potassium phosphate were added. When less 
than rS mM P1 was present, Tris buffer was added to compensate for the change in osmolarity. 
6o sec after the addition o£ the mitochondria, 4.8 mM sodium pyruvate was added. Qo2 values 
are expressed as ,ul 0 2 per mg protein per h. 
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pyruvate oxidation was not seen. This suggests that also in coupled mitochondria 
excess P1 can result in inhibition of pyruvate oxidation, when the malate supply in 
the extramitochondrial space is limited. 
The concentration of P1 in the mitochondrial and extramitochondrial compart-
ment varies in vivo, depending on the conditions. The observations reported in this 
paper suggest that a P,-induced exchange of citric acid cycle intermediates may play 
an important role in the regulation of metabolism in vivo. 
We wish to thank Drs. A. Van To! and J. M. Tager for help and criticism and 
Miss C. Kalkman for skilful technical assistance. 
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SUM).1AR"'£ 
I. Vilith the aid of marker enzymes, mitochondrial and microsomal fractions of 
rat-liver, heart and jejunum epithelium \vere characterized. In heart the palmitoyl-
CoA synthetase activity was shown to be localized maialy in the sarcosomes; in 
intestine the microsomes were the site of long-chain acyl-CoA synthesis, while in liver 
mitochondria and microsomes were about equally active in catalyzing palmitoyl-CoA 
synthesis. 
z. Nagarse treatment almost completely destroyed the cardiac and hepatic 
palmitoyl-CoA synthetase activity, in contrast to several other membrane-bound 
enzymes. 
!)JTRODUCTION 
In a previous study1 the relative contribution of the ATP-dependent fatty acid 
activating enzymes2• 3 [acid:CoA ligase (AMP), EC 6.z.r.z and EC 6.2.!.3] and the 
GTP-linked fatty acid activation system4 was investigated. In sonicated rat-liver 
mitochondria the "GTP system" had 3--6% of the activity of the "ATP system", 
when octanoate, palmitate or oleate were used as substrates. VvTe suggested that the 
"GTP system" was of minor importance in rat-liver mitochondria1 • 5 ·'>. Further 
research was therefore focused on the ATP-dependent long-chain fatty acyl-CoA syn-
thetase in mitochondrial and microsomal fractions of several tissues. 
KORNBERG AND PRICER3 found in I953 biosynthesis of long-chain acyl-CoA as 
well in soluble as in insoluble fractions of guinea pig liver. BoRGSTR0M AND WHEEL-
DOK7 reported the occurrence of the enzyme in liver mitochondria and microsomes of 
the same species. VrGKAIS et al.8 found the highest rate of palmitoyl-CoA production in 
rat brain in the soluble fraction. Later work revealed that also intestinal preparations 
from several species contained palmitoyl-CoA synthetase activity. Concerning the sub-
cellular localization in intestinal epithelium contradicting results have appeared9 - 12 • 
Several workers estimated the activation of palmitate in rat liver1 ,5.l3 - 19. A wide 
range of specific activities in subcellular fractions (mostly mitochondria. and micro-
somes) of liver was reported. Finally GALTON AND FRASER20 communicated palmitoyl-
CoA synthetase activity in adipose tissue homogenates. 
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There seemed to be a remarkable dearth of reports on long-chain acyl-CoA 
synthetase in muscle preparations, although fatty acid oxidation is the main source 
of energy in cardiac muscle, if the concentration of long-chain fatty acids in the coro-
nary blood is sufficiently high. We therefore investigated the ability of rat-heart 
fractions to synthesize palmitoyl-CoA. 
We measured the palmitoyl-CoA synthetase activity in liver, gnt and heart 
by a method developed in our laboratory14. This assay, a modification of the method 
described by FARSTAD et ai.", in which the palrnitoyl-CoA formed was trapped with 
L-carnitine as pahnitoylcarnitine, made it possible to avoid the hydroxylamine trap 
commonly used. While this work was in progress, we discovered the destructive effect 
of N agarse (subtilopeptidase A, EC 3-4+I6) treatment of heart homogenates on the 
palrnitoyl-CoA synthetase activity. 
EXPERIMENTAL 
Reagents 
From Serva Entwicklungslabor, Heidelberg, Nagarse was purchased. Other 
enzymes and nucleotides were obtained from C.F. Boehringer and Sons, Mannheim. 
Bovine serum albumin, Fraction V, was supplied by Sigma Chemical Co., St. Louis, 
Mo., or by Pentex Inc., Kankakee, Ill. Fatty acids were removed from albumin by 
charcoal treatment21• After dialysis and Millipore filtration the albumin was used as 
a clear, neutral solution. Albumin-fatty acid complexes in a I :7 molar ratio were 
prepared by adding to the albumin an adequate amount of recrystallized potassium 
palmitate in water. Oligomycin and kynuramine were obtained from Sigma Chemical 
Co., rotenone from Penick and Co., New York, N.Y. 
DL-[Me-3H]Carnitine was kindly donated by Dr. J. Bremer (Oslo). The radio-
active carnitine was diluted with L-carnitine chloride, supplied by Koch-Light Lab. 
Ltd., Colnbrook, to a specific activity of 0.032 mCjmmole L-carnitine. 
Preparations 
Male Wistar rats, weighing 200--250 g, used for liver and heart preparations, 
had free access to food and water. When intestine was needed, rats were treated 
per os one week before use with Metronidazolum [r-(2-hydroxyethyl)-2-methyl-5-
nitroimidazole] (about 4 mgj24 h, for at least 5 days) to get rid of intestinal Tricho-
monas vaginaiis22• The rats were fasted for about 48 h. All rats were killed by cervical 
fracture and subsequent bleeding. After removal of the organs care was taken to keep 
the preparations at o-4 °. Centrifugational g values refer to the bottom of the tube. 
Liver was immediately chilled in 0.25 M sucrose-ro mM Tris-HCI (pH 7-4)-
The liver was weighed, cut into small pieces and washed with sucrose-Tris to remove 
blood constituents. A ro% (wjv) homogenate was prepared by grinding at low speed 
in a Potter-Elvehjem homogenizer with a Teflon pestle. The liver homogenate was 
subsequently centrifuged for 5 min at goo X gin a Sorvall RC2-B centrifuge (Rotor 
SS-34) to remove nuclei, intact liver cells, erythrocytes and debris. The supernatant 
fluid was taken and centrifuged for ro min at 5roo x g. The precipitate of (heavy) 
mitochondria was suspended in half the original volume of sucrose-Tris and cen-
trifuged for 10 min at 12000 X g. The :fluffy layer was removed from the mitochon-
drial pellet by gently shaking with small amounts of sucrose-Tris, and the mitochon-
Biochim. Biophys. Acta. 197 (1970) 127-135 
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<hial fraction was resuspended in sucrose-Tris with the aid of an homogenizer. The 
5100 X g supernatant fluid was also spun for IO min at 12000 X g. The precipitate, 
consisting mainly of light mitochon<hia, was discarded. The supernatant fluid was 
centrifuged for so min at I3S ooo X g in a Becl.-man Lz-6sB ultracentrifuge (Rotor 
SW-27). The microsomal precipitate was washed with small amounts of sucrose-Tris 
and resuspended in this medium. 
From two rat hearts the aortae and auricles were cut away. The hearts were 
opened, washed with o.2s M sucrose-ro mM Tris-HCl (pH 7-4) to remove the blood, 
and weighed. The hearts were placed in o.2s M sucrose-s mM ATP-ro mM EDTA 
(pH 7.4). After chopping with a Mcilwain tissue slicer"', the mince (about 5% wjv) 
was subjected to the (hand-operated) homogenizer mentioned above. The mince was 
magnetically stirred for 30 min and once more subjected to the homogenizer. The heart 
homogenate was centrifuged for S min at 500 X g in the Sorvall centrifuge. The 
supernatant fluid was centrifuged for ro min at rzooo x g. The sarcosomal pellet 
was \vashed with a small amount of sucrose-Tris, carefully suspended in sucrose-Tris 
(about half the original volume) and recentrifuged for ro min at 12000 X g. The 
sediment was suspended" in sucrose-Tris after rinsing the pellet. A heart microsomal 
fraction was prepared from the first rzooo x g supernatant fluid by centrifugation 
for so min at 135000 X g. 
From two rats the jejunal portions of each intestine were taken and rinsed with 
o.rs M NaCL According to the method of SJ6STRAND24 mucus was removed with s% 
(wjv) Ficoll-<>.IS M NaCl, and intestinal epithelial sheets were prepared in 2% (wjv) 
Ficoll-o.rs M NaCl-<>.2 M sucrose (pH 7.4) and collected by centrifugation. The cell 
sheets were washed and finally homogenized. Further details of the preparation of 
the homogenate and the differential centrifugation will be described by IEMHOFF 
et al.22. In short thehomogenatewascentrifuged for IO min at rooo X g. The sediment 
was rehomogenized and again centrifuged. The combined rooo x g supernatant fluids 
were centrifuged for ro min at IS ooo X g. The resulting mitochondrial pellet was 
washed with a small amount of sucrose-Tris, suspended and recentrifuged. The sedi-
ment was considered to be the intestinal mitochondrial fraction. The combi.tJ.ed 
IS ooo x g supernatant fluids were centrifuged for 6o min at 368 ooo x gin the Beck-
man centrifuge (Rotor 6s). The pellet was rinsed and suspended in sucrose-Tris and 
was designated the intestinal microsomal fraction. 
Caruitine palmitoyltransferase was purified from calf-liver mitochon<hia as de-
scribed by FARSTAD et a£. 13. 
Palmitoyl-CoA was synthesized according to SEUBERT25. 
Methods 
Enzyme assays were carried out at 37°. 
Palmitoyl-CoA synthetase [acid:CoA ligase (AMP), EC 6.2.):.3] activity was 
determined according to FARSTAD et al.13, as modified by VANToL AND HULSMANNH. 
Palmitoyl-CoA formed from palmitate, coenzyme A and ATP by mitochondrial or 
microsomal fractions was converted to palmitoyl[3H]caruitine by added [3H]cami-
tine and camitine palmitoyltransferase. The incubation mixture consisted of r mM 
potassium palmitate-<>.I4 mM albumin, 2 roM ATP, 0.2 mM coenzyme A, s mM 
[3H]carnitine (specific activity, 0.032 mCjmmole L-caruitine), 0.3-<>.5 mg purified 
camitine palmitoyltransferase (0.04-D.I U), 5 mM phosphoenolpyruvate, about r.s U 
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pyruvate kinase (EC 2.7.1.40), about L5 U adenylate kinase (EC 2.7-4-3), 20 mM KCl, 
2 mM MgCl2, 120 mMTris-HCl buffer, 0.5 roM EDTA and 3 #g oligomycin. The reac-
tion was started by the addition of o.r-o.3 mg mitochondrial or microsomal protein, 
usually in o.r ml 0.25 M sucrose-ro mM Tris-HCl (pH 7.4). Incubation times up to 
IO min were used. The final volume was r.o ml and the pH 7·4· The reaction vvas 
stopped by addition of HC!, and palmitoyl[3H]carnitine was extracted into n-butanoP3. 
Aliquots of 0.5 ml were transferred to counting vials. The scintillation mi.xture con-
sisted of ro ml toluene contaL.J.ing 50 lilg z,s-diphenyloxazole (Packard) and 3 mg 
I,4-bis-[2-(4-methyl-5-phenyloxazolyl)]benzene (Packard), while 0-4 ml NCS solu-
bilizer (Amersh<h"n/Searle Corporation) was added to each counting vial. The counting 
efficiency for tritium was about 30% as detennined by the channels ratio method. 
Glucose-6-phosphatase (EC 3.I.3.9) activity was assayed as described in ref. z6. 
Liberated inorganic phosphate was determi:1ed in deproteinized samples as described 
by SUMNER27• 
Monoamine oxidase (EC I-4·3-4) activity was measured according to \VEISS·· 
BACH et al.28, using kynuramine as the substrate. 
Cytochrome c oxidase (EC r.g.J.I) activity was determined by the method of 
SoTTOCASA et al. 29 in which a Clark oxygen electrode was used. In the case of heart 
sarcosomes, freezing and thawing several times was necessary to obtain ma."Ximal 
activity. 
Alkaline phosphatase (EC 3-I.3.I) activity was assayed at pH ro.5 with p-nitro-
phenylphosphate as the substrate30• 
NADPH cytochrome c reductase (EC r.6.2.3) activity was measured in the 
presence of o.rs p;M rotenone by following the reduction of cytochrome cat 550 nm29 • 
Carboxylesterase (EC 3.r.r.r) activity was measured manometrically as de-
scribed by HuLSMANN31 (see also refs. 32 and 33). Glyceroltributyrate was used as 
the substrate. ro-6 M eserine was included in the incubation medium to inhibit the 
cholinesterase (EC 3.r.r.8)33• 
Carnitine palmitoyltransferase activity was assayed according to NORUM34 with 
palmitoyl-CoA as the substrate. Protein was determined by the biuret method as 
described by jACOBS et al.35• 
RESVLTS AND DISCUSSION 
Liver 
Table I shows the specific activity of the long-chain acyl-CoA synthetase in 
liver mitochondrial and microsomal preparations together with the activity of some 
enzymes from which the cross-contamination can be calculated. From the distribution 
of these marker enzymes it can be concluded that no gross amounts of mitochondrial 
inner membranes (marker: cytochrome c oxidase36) or outer membranes (marker; 
monoamine oxidase36,37) pollute the microsomal fraction. Comparatively more micro-
somes contaminate the mitochondrial fraction. It can be seen from Table I that the 
microsomal marker enzymes glucose-6-phosphatase38, NADPH cytochrome c reduct-
ase29·39 and carboxylesterase (cj. the review given by HAYASE AND TAPPEL40) in the 
mitochondrial fraction of liver have between rz and rS% of the specific activities of 
these enzymes in the microsomal fraction. DE DuvE et al. 38, FARSTAD et al.13 and 
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VANTOL AND HDLSMANN14 reported that the heavy plus light mitochondrial fraction 
had about the same protein content as the microsomal fraction. From the specific 
activities of palmitoyl-CoA synthetase ;..., Table I it can be concluded that the long-
chain acyl-CoA sy--nthetase activity in rat-liver mitochondria and rnicrosomes is ap-
proximately the same. 
From refs. r a..Tl.d 13-17 it can be seen that quite different specific activities are 
obtained by various investigators for the palmitoyl-CoA synthetase in rat-liver mito-
chondria and microsomes. These discrepancies may be due to: (r) hormonal and 
dietary fluctuations, (z) the lability of acyl-CoA synthetase, as has been noticed by 
BoRGSTR0M P..ND W:a:EELDOK7, andjor (3) different fractionation methods and activity 
determinations'"". 
The dual localization of palmitoyl-CoA synthetase ag7ees with the concept of 
the liver as an organ which consumes fatty acids by oxidative processes in the mito-
chondria, in addition to producir.g triglycerides and phosphatides mainly in the micro-
somes. After their synthesis in the microsomes the bulk of the lipids is passed into 
the systemic circulation. 
Heart 
Rat heart yields a relatively small amount of microsomes on homogenization 
(Table 1)32 ,·11• The rat-liver microsomal markers NADPH cytochrome c reductase29 • 39 
and carboxylesterase32 ,4.0 exhibit also in heart the highest specific activity in the ex-
pected microsomal fraction (see Table I and ref. 32). From the specific activities of 
cytochrome c oxidase, a marker enzyme for heart sarcosomes32 •·12, and the afore-
mentioned microsomal markers ir.. the sarcosomal and microsomal fractions, it can be 
concluded that a mutual contamination of 20-25% exists. From Table I it can be 
seen that the specific activity of the palmitoyl-CoA synthetase is somewhat higher in 
the microsomal fraction. Hence it can be concluded that heart microsomes are able 
to activate palmitate. Their contribution to the total fatty acid activation of heart 
cells, however, is small,< IS% of the mitochondrial activation. 
Heart musde, contra.t-y to liver, mainly consumes fatty acids as substrates. 
In order to maintain an appropriate ATP level ior contraction, acyl-CoA is broken 
down in the sarcosomes. The :finding of a palmitoyl-CoA sy:1thetase in the sarcosomes 
is therefore not unexpected. That heart microsomes do not contribute ve;:y much 
to fatty acid activation is in agreement with the function of the organ. The organ 
mainly generates mechanical work and does not, unlike liver, produce large amounts 
of substrates for the benefit of other organs. 
Intestine 
Table I shows the palmitoyl-CoA synthetase activity in mitochondrial and 
microsomal fractions of rat-i...'"ltestinal epithelial cells. Cytochrome c oxidase has been 
used as a marker for intestinal mitochondria3 • '13 • Carboxylesterase is a microsomal 
enzyme in rat liver4° and heart32. NADPH cytochrome c reductase, which has been 
used by CLARK ei a£:!3 as a marker of the endoplasmic reticular fraction to differentiate 
it from membranes of the brush border portion of intestinal cells, shows essential!y 
the same distribution pattern as oarboxylesterase (Table I). The mitochondrial frac-
"'Using either the carnit£ne- or the hydroxylamine-trapping met."'lod1!.i, in our hands the high 
acyl-CoA synthetase activity in the nuclear iraC'tion, as reported by PA~DE AND MEAD"l&, is absent. 
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TABLE I 
FATTY ACID ACTIVATION IN RAT-LIVER, HEART AND GUT FRACTIONS 
\\1here indicated the following markers have been used: cytochrome c oxidase and monoamine oxid<~.se fm the IIlituchond!"i<l; glncose-6-phosphatasc, 
N ADPH cytochrome c reductase and carboxyle~tcrase for the microsnmes. Enzyme activities are given in nmoks/min per mg protein at 37 "'. Statistics 
refer to means ± S.D.; 11 = number of experiments. 
Liver Hearl Gut 
.----- .--
" 
M itocho11dria 
" 
.Microsomcs 
" 
Mitochondria 
" 
i\licrosomes 
" 
Mitoclwlld~ia 
" 
11! icrosomes 
-------- ----------
Protein (mgfg tissue, wet wt.) 5 2J.8 ± 5·5 4 25-3 ± l0.4 7 10,2 ± 1.8 3 I.48 ± o.:q 3 I.] ± 0.2 3 2.3 ± 0.] 
Palmitoyl-CoA synthetase 6 82,3 ± 20.6 
(.d palmitoylcarnitine) 5 
77·0 ± IJ.] 7 26.8 ± 2.2 3 38-3 _t ;.8 3 ro.S ± 4.6 3 2J.I _±: 6.6 
Cytochrome c oxidase (- LI02) 5 8o8 ± 309 4 IJ ± 16 7 1720 ± 280 3 6oo ± 6o 3 200 ± ·17 3 12.7 ± g.6 
Monoamine oxidase 
·1 9·7 ± 1.5 3 1.7 ± o.S (- .d kynuramine) 
Glucose-6-phosphatase (.d Pt) 4 46 ± 12.8 3 250 ± 12.2 - -
NADPH cytochrome c reductase 4 23 ± 8.8 3 tfl2 ± 62 4 s.s ± 1,0 
' 
34·2 ± 0.8 3 30 ± fl.J 3 34·2 ±g. I {LI cytochrome c reduced) 
Carboxylesterase (LI C02) 3 Lj2 ±57 3 1120±281 
' 
65 
' 
'26g 3 7(J7° ± 509 3 II 400 ± 494 
Alkaline phosphatase - 3 J.~ ± o.8 3 43·5 ± 1.9 {J p-nitrophenol) 
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PALMITOYL-CoA SYNTHETASE I33 
tion, when corrected for the apparent microsomal contamination, seems to lack pal-
mitoyl-CoA synthetase. Tbjs conclusion is in agreement with the fmdi.~gs of SENIOR 
AND !SSELBACHER10,1l and AILHAUD et al.9• These investigators made use of alt.:.aline 
phosphatase as a microsomal marker-9, 11• EICHHOLZ AND CRANE44, however, showed 
that at least in hamster this enzyme is localized in bru.sh borde:- meBbranes (see also 
refs. 45 and 46). The an~aline phosphatase activity LJ. the microsomal f:-action (see 
Table I) results, in part, from contamination with brush border fragments as ca..."I"J. be 
concluded from the sucrase (EC 3.2.r.26) activity"13• After separa'~ion of the b:--.1sh 
border fragments from the rricrosomal fraction, it was shown that in the brusl1 border 
almost no long-chain acyl-CoA synthetase activity was preser:t (Dr. J. Yfl/. 0. Van 
den Berg, personal comm1l!lication). FORSTNER et a£.'17 reported a specific ac:tiv"ity of 
synthetase in the brush borders of I/5 that of the microsomes. From. our expelli""r..ents 
it can be concluded that in rat-gu.t palmitoyl-CoA synthetase is reainly o;: even com-
pletely a microsomal enzyme. For preparative reasons intestinal fractions \vere 
obtained from fasted rats. SENIOR A::-.rD IssELBACHER11 stated that fasting did not 
in:fiuence the rat-intestinal palmitoyl-CoA synthetase. 
The activity found by us, 23 nmolesjmin per mg proteLtJ. at 37°, is higher than 
that reported by SENIOR AND IssELBACHER11 (3-I7 nmolesjmin per mg protein). 
RoDGERs48, who used the method of SENIOR AND IssELBl£HER (fatty acyl-hyd:roxam-
ate formation), measured a specific activity of 97 nmolesjrnin per mg proteiiJ.. 
In the digestive tract fat from nutrients is attacked by lipases of the succus 
entericus. Free fatty acids and monoglycerides are subsequently absorbed by the 
epithelium cells of the small intestine. Evidence has been presented that fatty acids 
are activated h"""l the intestinal mic:rosomes (Table I, refs. 9 and Io). The acyl-CoA is 
used for (microsomal) triglyceride and phosphatide synthesis10- 12, after which these 
TABLE II 
INF!..UENCE OF NAGARSE TREATMENT OF RAT-HEART .!'.ND LIVER HOMOGENATES ON THE ACTIVITY 
OF SEVER.t'..L MEMBRANE-BOUND ENZYMES 
11itochondrial and microsomal preparations were isolated from :five rat hearts as described under 
Preparations. Before being stirred for 30 min at 0° 5 m.g Nagarse were added to or..e half of the 
mince. In the case of liver, !5 mg Nagarse were added to one half (5o ml) of a ro% homogenate. 
Both homogenates were stirred for 30 min at 0° prior to differential centrifugation as described 
under Preparations. 
Fraction En::ymc Specific activity 
(nrnolesfmin per mg protein) 
-Nagarsc +Nagarse 
Heart 
Mitochondria Palntitoyl-CoA synthetase 27·5 O.j 
Cytochrome c oxidase 1560 qro 
~crosomes Palmitoyl-CoA synthetase .;.o.o o.S 
NADPH cytochrome c reductase 35·0 2.2 
Carboxylesterase 270 245 
Liver 
Mitochondria Palmitoyl-CoA synthetase 53·3 I.O 
Monoamine oxidase 9-2 10.3 
Microsomes Palmitoyl-CoA synthetase 66.7 0.0 
NADPH cytochrome c reductase 26] 25 
Glucose-6-phosphatase 250 237 
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lipids enter the organism mainly via the intestinal lymphatics. In contrast to heart 
cells, the intestinal cells are mainly involved in the production of lipids for other 
organs. Therefore utilization of lipids for the proper function of intestinal epithelial 
cells is quantitatively of minor importance. Hence, it is understandable that in the 
gut the endoplasmic reticulum is the main site of fatty acid activation. This tubular 
system can function for large molecules or complexes like chylomicrons as a secretory 
pathway leading to extracellular ~paces49 . 
Ir:. earlier experiments with rat heart, emplo:y'"L1g the method of CHANCE AKD 
I-IAG:::EAR.-\50 for preparing sarcosomes (with Nagarse). it was not possible to find 
sig:;-,ificant long-chain acyl-CoA synthesis. The purpose of the use of Nagarse was to 
oJtain more sarcosomal protein. The sarcosomes showed excellent respiratory ca-
paci:y, good oxidative phosphorylation and respiratory control ratio;a with va..-ious 
s:.:tOstrates (cf. refs. 52-54). However, it can been seen from Table II that Nagarse 
treatment destroys the fatty acid activating enzyme. Mitochondrial inner membra."le 
and matrix enzymes are probably not accessible to Nagarse. A certain specificity of 
Nagarse inactivation, which may be useful in localization studies, can be concluded 
from Table II. In the study of fatty acid oxidation Nagarse treatment could conceiv-
ably be used to eli.'Uinate the mitochondrial outer membrane and microsomal long-
chain fatty acid activating enzyme. 
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Effects of Nagarse, adenodne and hexokinase on palmitate activation 
and oxidation 
In a previous investigation' it was demonstrated that Nagarse (subtilopeptidase 
A, EC 3+4-I6} almost completely destroyed rat heart and liver mitochondrial 
palmitoyl-CoA synthetase [acid:CoA ligase (AMP), EC 6.z.r.3] activity (see also ref. 
z}. Nevertheless Nagarse-treated liver mitochondria showed intact palmitate oxida-
tion, in contrast to similarly treated heart sarcosomes (Table I). 
TABLE I 
l!"FLUE~CE OF NAGARSE TREATMENT O:N PALMITATE OXIDATION IN LIVER AND HEART MITOCHONDRIA 
Mitochondrial fractions were prepared in the presence or absence of N agarse as described beforet. 
0 2 uptake was measured with differential manometers at 25° as given in ref. 3· Reaction vessels 
contained 0.25 mM [r-14C]palmitate (o.2 p,Cjp,mole),o.o4 mM dialysed bovine serum albumin, 
r.o mM L-malate, 2.5 mM ADP. 25 mM potassium phosphate {pH 7.4), 25 mM D-glucose, 5.0 mM 
MgCl:, zo mM KCl, r.o mM EDTA, 75 mM Tris-HCl buffer {pH 7.4), 2.4-3.8 mg mitochondrial 
protein and 25 mM sucrose. Further additions v.:ere dialysed hexokinase (3.2.I.U.) and 2.5 mM 
L-carnitine as indicated below. The reaction was terminated by the addition of o.o5 ml 70% 
HC104 after 42.5 min (liver) or 41 min (heart). Shaking was continued for 3o-6o min. The 
KOH soaked paper in the centre well was transferred with ro ml scintilL-"1.tion mixture1 to a 
counting vial. After addition of r ml r M hydroxide of hyamine in methanol {Packard) and 
vigorously shaking, 14C02 was measured with a counting efficiency of approx. 70%. Toi.al 0 2 
consumption was calculated by extrapolation. 
0 2 uptake UC02 production ( £ pJ jmg protein) (counts/min per mg protein) 
Hexokinase: -Nagarse +Nagarse -Nagarse +Nagarse 
+ + + + 
Liver 
No palmitate added 7 H 6 I2 
Palmitate 8 25 8 25 gS 2887 78 2628 
Palmitate+ carnitine 9 29 IO 23 65 3314 82 2917 
Heart 
No palmitate added 7 7 '2 5 
Palmitate 7 4 '5 6 86 38 q6 36 
Palmitate+carnitine 43 3 I6 5 6328 43 687 30 
The oxidation of palmitate by liver mitochondria was stimulated by the 
addition of hexok-inase (EC z.J.I.I}, in contrast to heart mitochondria where this 
addition was strongly inhibitory. Furthermore, when ADP or AMP were added as 
phosphate acceptor instead of hexokinase, a stimulation of hepatic palmitate oxida-
tion was observed, whereas these nucleotides, and also adenosine, were inhibitory 
when heart mitochondria were used. Other substrates like palmitoylcamitine or 
Biochim. Biophys. Acta, 2IO (1970) 499-501 
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pyruvate exhibited in both tissues much higher oxidation rates on ADP or AMP 
addition (not shown). 
Estimation of palmitoyl-CoA synthetase activity in sonicated heart sarcosomes 
showed that, in the presence of hydroxylamine, ADP practically did not inhibit, 
but that AMP and adenosine, in contrast to, e.g. inosine, clearly inhibited (Table II). 
The strong inhibition by adenosine was also observed when liver mitochondria 
were used instead of heart sarcosomes (not shown). In heart and in liver mitochondrial 
sonicates a K 1 for adenosine inhibition of palmitate activation of o.r mM could be 
TABLE II 
ADE~OS!NE INHIBITION OF HEART SARCOSOMAL PALMITOYL-CoA SY:NTHETASE 
Rat heart sarcosomes, prepared as described before1, were sonicated. Palmitoyl-CoA synthetase 
activity '\Vas determined at 37" according to PANDE AND MEAD"·s with 0.94 mg sarcosomal 
protein, 15 mM ATP and 1.2 roM CoASH. The incubation time was 30 min. 
Adtlition Specific activity Inhibition 
(z mM) (nmolesfmin per mg protein) (%) 
None 33·8 
s'-ADP 32 ·5 4 
5'-AMP zS.5 I6 
3',5'-cyclic AMP 31.0 8 
Adenosine 4·4 87 
Deoxyadenosine 21.9 35 
Inosine 34·5 0 
Adenine zS.r '7 
calculated. When liver mitochondria were prepared in the presence of N agarse 
(which destroyed about 95% of the pahnitoyl-CoA synthetase activity'·'), the 
residual palmitoyl-CoA synthetase was hardly sensitive to adenosine. This residual 
activity could be sufficient for fatty acid oxidation, since palmitate oxidation in 
liver mitochondria was not impaired by the addition of 2 mM adenosine. 
It is concluded that under the conditions described in Table I, palmitate 
oxidized by liver mitochondria is presumably activated by a palmitoyl-CoA syn-
thetase localized in the inner membrane-matrix compartment, because (i) Nagarse 
treatment does not effect liver palmitate oxidation (Table I); (ii) hexokinase addition 
causes an increase of liver palmitate oxidation (Table I), although at the locus of 
the outer membrane palmitoyl-CoA synthetase, the ATP level can be expected to 
be extremely low; (iii) no inhibition of liver palmitate oxidation is observed on 
addition of adenosine, although the outer membrane, Nagarse-sensitive, palmitoyl-
CoA synthetase is severely inhibited by adenosine; (iv) carnitine hardly stimulates 
liver palmitate oxidation (Table I). The palmitoyl-CoA which is used for oxidation, 
is probably generated by an ATP-dependent system rather than a GTP-dependent 
one', since substitution of GTP for A TP (see also ref. 7) in the palmitoyl-CoA syn-
thetase assay', employing Nagarse-treated liver mitochondria, results in an So% drop 
of activity. 
In heart sarcosomes palmitate is activated on the outside, which makes pal-
mitate oxidation N agarse-, adenosine- and hexokinase-sensitive and strongly carnitine-
dependent (Tables I and II). Whether the effect of adenosine, reported in this paper, 
is of physiological significance, remains to be investigated. It may be of interest to 
note that BERNE8 reported adenosine release in the hypoxic heart. 
Bioclzim. Biophys. Acta, zro (rg7o) 499--501 
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INFLUENCE OF ADENOSINE AND NAGARSE ON PALMITOYL-CoA 
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SUMMARY 
r. A Q10 of about 3 for palmitoyl-CoA synthetase (EC 6.2.r.3) in rat heart and 
liver mitochondria is found. 
2. In heart mitochondria Nagarse (EC 3-4+I6) destroys the ability to activate 
palmitate. \iVhen, however, heart mitochondria are oxidizing palmitate, they are pro-
tected from the inactivating action of N agarse. 
3- Although treatment of liver mitochondria with Nagarse causes the loss of 
about 95% of the palmitoyl-CoA sy-nthetase activity, no influence is observed on 
palmitate oxidation. 
4- Adenosine inhibits palmitoyl-CoA synthetase in liver and heart mito-
chondria. Adenosine is a compe6tive inhibitor with respect to ATP with an apparent 
Ki of o.r mM. The residual palmitoyl-CoA synthetase in Nagarse-treated liver mito-
chondria is much less sensitive to adenosine. 
5- 2 mM adenosine or 2 mM adenosinesulfate inhibit palmitate oxidation (in the 
presence of z.s mM ATP) in heart mitochondria 6o-go ~~. 
6. The data obtained are consistent with the concept of a palmitoyl-CoA 
synthetase localized on the outside of the outer membrane of rat heart and liver 
mitochondria, with an additional locus of (ATP-dependent) palmitoyl-CoA synthesis 
in the inner membrane matrix compartment of liver mitochondria. 
INTRODUCTION 
It was shown in a preliminary note1 that adenosine strongly inhibited ATP-
dependent palmitoyl-CoA synthetase (acid:CoA ligase (AMP), EC 6.2.r.3) activity 
in rat heart and liver mitochondrial sonicates. In the present communication further 
details are given about the specificity of this inhibition. Furthermore, the influence of 
adenosine on palmitate oxidation by mitochondrial preparations is shown. 
DE J ONG AND HULSMAOH<2 and PANDE AND BLANCHAER3 independently ob-
served that Nagarse (subtilopeptidase A, EC 3+4-I6), often used to isolated mito-
chondria from cardiac muscle, acted destructively on palmitoyl-CoA synthetase in 
heart mitochondria. The same was found in liver mitochondrial and heart and liver 
microsomal preparations2. The available evidence indicates that the highly active 
palmitoyl-CoA synthetase on the outside of the outer membrane of mitochondria is 
Biochim. Biophys. Acta . ..!-f5 (r97Il z~S-298 
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destroyed1 • 4• Whether there is a separate ATP-dependent palmitoyl-CoA synthetase 
i.'1. the i..Tlller mem-brane matrix com"9a..-'-w:nent. is still a matte::c of discussion. VANToL 
AND HULSMANN'' a....··uJ SKREDE AND BREMER::; noticed. a small_. but distinct. ATP-
ciependent long-chah;. :fatty add activatior: in the inner membrane matr ..... x fraction 
of rat liver :nitochondria (see also VAK DEN BERGE ei al.<:. and LIP?EL AND BEATTIE7). 
However, in. a ve..-y recent paper A . .:..sf, di<i not :find. conclusive evidence for activatior: 
of palmitate iu the inner membra.r.J.e or matrix f~action of liver mitochonlli-ia. ALL:M..4..NN 
ct al.9 performed localisation studies witt ':Jeef hear: mitochondria (but see re:. :w). 
In :..b..is paper some experiinen-cs are presented. which are in_ agreement with the 
concept o-£ an ATP-d.ependent palmitoyl-C.oA s;rnthetase situated o:r: the outside of 
the outer membrane of rat hea_rt and.. liver mitochondria, with an additional locus of 
f/,.TP-dependent) palmitoyl-CoA sy"Dthetase in the inner membrane mat? ...... -x compart-
ment of l:iver mitochondria. TOe kineti~ properties of tlle two differently localized 
enzyrnes i:r: liver mitochond..ria provide further indirect support of two separate 
palmitoyl-CoA synthetases. 
EXPERIMENTAL 
Reagenis 
Nagarse was furnished by Serva Entwicklungslabo:r, Heidelberg. Adenosine 
(puriss.) and other nudeosiO..es were purchased from Kocl-;.~Light Lab._. Colnbrook, 
Bucks. AO..enosL11esuliate, 2~ -AMP and 3' -AM:? were obtained from Schuchardt, 
Munich. Cyclic 2',3'-AM:P was porchased. from Sigma Chemical Co., St. Louis, Mo., 
whereas ofner nucleotides and enzymes were irom C. F. Boehringer und Si::ihne, 
Mannheim. Coenzyme A anci sodiu...u pyruvate (Boehri:Qger) were solved just before 
use. Bovine serum albumin (frorr. Pentex Inc., Kankakee, Ill.) was defatted by char-
coal treatmentu and dialyzed. ~!-1-tCJPalmitic acid was supplied by The Radio-
c-hemical Centre, Amersham, diluted vvith potassium palmitate and complexed to al-
bumin in 2. 7: r molar ratio as described before2• In the same reference the source 
of DL-[.Me-3HJcarnitine is acknowledged. 
Preparations 
Rat heart and liver mitochondria were isolated as described before2• For the 
experiments shown in Table IV and Figs. 4 and 5 the heart mitochondria were not 
subjected to the rzooo x g centrifugation step. Sonicates of the mitochondrial frac-
tions were prepared at o~s o wi.th a MSE roo-W Ultrasonic Disintegrator (Measuring 
and Scientific Equipment Ltd., London), operated with a microtip at ZI kcyclesfsec 
(amplitude 6.5 p.m. peak to peak) for 6o sec(ml of suspension. at least when the 
mitochondrial protein concentration was below 20 mgjml. Otherwise the sonication 
time was doubled. 
Carnitine paJ.rrjtoyltransferase (palmitoyl-CoA: carnitine 0-palmitoyltrans-
ferase, EC 2.3.r.-) was puriiied from calf liver mitochondria as described by FARSTAD 
et al.12• 
Methods 
Palmitoyl-CoA synthetase activity was assayed either as the formation of pal-
mitoylhydroxamate according to PANDE AND l\IIEAD13·" or as the synthesis of fH]-
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palmitoylcarnitine in the presence of ["H]carnitine andcarnitinepalmitoyltransferase. 
The latter method was described by FARSTAD et al.'2• and modified in our laboratory2• 15• 
Oxygen uptake was determined in a vessel equipped with a Clark oxygen elec-
trode (Yellow Springs Instruments Co .• Yellow Springs, Ohio) and a Micrograph BD5 
recorder (Kipp en Zonen, Delft) or manometrically with a differential respirometer 
(Gilson Medical Electrouics, Villiers-le-Bel, France). Calibration of the electrode was 
performed with NADH and catalase (cj. RoBINSON AND CooPER"). 
Protein was measured by the biuret method as described by jACOBs et al.". 
Radioactivity was estimated in a Nuclear-Chicago 720 liquid scintillation 
counter. 14C02 was COlli"lted with an efficiency of about 65% in IO ml of the mixture 
of toluene, Triton X-Ioo and ethanol (containing PPO and POPOP) described by 
PATIERSON AND GREENE18. 
RESULTS AND DISCUSSION 
Kinetics of the inhibition of palmitoyl-CoA synthetase by adenosine 
Fig. I shows the inhibition of palmitoyl-CoA synthetase by various concentra-
tions of adenosine with isolated heart mitochondria. With these mitochondria a normal 
Dixon plot (concentration of inhibitor versus the reciproke value of the activity at 
two ATP concentrations, cj. ref. Ig) is obtained. The K, for adenosine is o.I mM 
(two separate experiments). The inhibition is competitive with respect to ATP. 
In preparations of liver mitochondria the Dixon plot obtained for the inhibition 
of palmitoyl-CoA synthetase by adenosine does not give one straight line (Fig. z). 
In this case a K, of o.I mM (two experiments) is found when the concentration of 
.inhibitor is less than about I mM (see Fig. z, insert). This value was reported in the 
preliminary note1 and confirmed by VAN ToL AND H0LSMANK4 , who used a different 
assay. The inhibition is of the competitive type with respect to ATP. A second, much 
higher K, can be found by extrapolation of the values in the Dixon plot obtained for 
't. 
0.15 1fv T 0.10 T 
. .,
,_, 
" " " 
- mM Adenosine 
Fig. r. The Di.--::on plot of inhibition by adenosine of palroitoyl-CoA synthetase in sonicated rat 
heart mitochondria. Palmitoyl-CoA synthetase was assayed '\.Vith hydroxylamine according to 
PANDE AND MEAn13 · 14. The concentration of ATP was 4 mM (G-e) or 15 mM (.A.-A,). 2 mM 
palmitate and 1-.2 mM CoASH were present initially. The incubation was carried out with 0.54 mg 
mitochondrial protein for 30 min at 37 o. V = munitsjmg protein. 
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Fig. 2. The Dixo:1 plot of inhibition oi palmitoyl-CoA synthetase in sonicated ra't liver mito-
chonCLria. ln the assay (hydroxylamine method13) 0.3S--o.7o mg mitochondrial protein was used. 
The concentration of ATP was 4 mM ( 18-CD) or rs mM (A-A). Further conditions as indicated 
in the legend to Fig. I. 
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Fig. 3· Temperature dependence of pa!mitoyl-CoA synthetase in a heart mitochondrial sonicate. 
Palmitate activation was determined with the hydroxylamine methodl.S,H in the presence of 
2 mM potassium palmitate, 15 Illi'YI ATP. r.z rn.l\1: CoASH and 0.26-r.o mg mitochondrial protein. 
The incubation time was 3o-6o min. \Vhere indicated, the assay was carried out in the presence 
of 2.0 m.:.\1 adenosine. The insert shows the Arrhenius plot (rcciproke value of absolute temperature 
versus log (munitsjmg protein)) for palmitoyl-CoA synthetase without inhibitor. 
Fig. 4· Inhibition of palmitate oxidation in rat heart mitochondria by ADP. For the isolation of 
mitochondria see Preparations. Oxygen uptake was measured with a Clark oxygen electrode. 
The incubation medium contained 12.5 mM potassium phosphate, so mM KCI, r.o roM ATP, 
2.5 mM MgCl2, o.o2 mM Co ASH, 0.2 mM GSH, So mM Tris-HCl, 4.0 m.M EDTA, o.os mM cyto-
chrome c, 0.25 mM L-malate, o.o62 mM palmitatejo.or mM albumin and r.o mM L-carnitine. 
In the control 7·5 mM sodium pyruvate was substituted for palmitate+ carnitine. VJhere indi-
cated o.gS mg mitochondrial protein ( + 25 .umoles sucrose) and ro .umoles ADP were added. 
The final volume was 2.0 ml, the pH 7·4 and the temperature 30.0°. 
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adenosine concentrations higher than I mM. In liver mitochonili--ia a palmitoyl-CoA 
synthetase with high activity is located on the outside of the mitochond..-rion1• 4 • This 
activity is lost on treatment of the liver :mitochondria with Nagarsel.2.4. For Nagarse-
treated liver mitochondr:a a Ki value of o.z mM has been reported4 • When the hy-
droxa_mate assay is used instead of the ca.."TTiti...J.e assay (see 1Vlethods), Ki values of 
2-IO mM are found. Also in this case the inhibition is competitive with respect to 
ATP1 .4-. 
\Vhen the inhibition of palmitoyl-CoA synthetase by adenosine was investigated 
at several temperatures a very high Q10 for the activation of fatty acid was found. 
In the literature no experiments we:e fo1L"ld concerning the temperature dependence 
of palmitc.yl-CoA ss-.-l."l.thetase activity. Fig. 3 shows the activity of pa1"Tiitoyl-CoA 
S}Tllt~:"'tase at differe;1t temperatures L.J. the presence or absence of 2.0 mM adenosine 
T.-\GLE I 
TEMPERATURE DEPENDENCE OF PALMITA':"E ACTIVATION!:-< HEART MITOCHONDRIAL SO:-TICATES 
~.Ji"tochondrial frac~ions were prepared as described before~. Paimitoyl-CoA synthetase was de-
termined eith::-r with hyd:-oxylaminc13 or with ~3H~ca-rnitine1::!, as modified in ref. 15. Tnc amounts 
of mitochondrial protein and the incubation time for the forme:- are mentioned in the lcge:1C 
to Fig. 3· In the carnitine assay o.:::-o . ..;. mg enzy-matic protein, r.o mM palmitate/albumin. :::.o m:\I 
AT? and o.::: m}1 CoASH were u~ed. The incubation time was 6 min in this case. The results 
were arranged i:1 a:1 Arrhenius plot (cf. Fig. 3). iro:n which Q2 tl a;1d energy of activatior.. we:-e 
calculateC. 
Hydroxylamine assay 
Expt. I 
Expt. II 
~ 3H]Carnitinc assay 
Expt. I 
Exp~. II 
TABLE II 
Energy of 
activation 
(kcal· mole-1) 
23.6 
19·5 
rS.o 
19-3 
20-JO~ J0-.J0° 
3·98 3·64 
3- 1 3 :::.go 
:::.Si :::.6S 
3·0 3 z.SS 
I:-:THIBITION OF PALMITOYL·CoA SYNTHETASE IN SONICATED LlVER AND :rtEART :.!ITOCHONDRIA BY 
>rU::::LEOSIDES 
).1itochondrial fractions were prepared as described before2. The hydroxylamine assay v .. ·as carried 
out at 30"'" as given ir.. the legends to Figs. r and 2 with 15 mM ATP and z.o mM n~deoside. 
Avera.~e values were Calculated for 3-6 experiments. The specific activitv of the enz:vme without 
inhibitor was 31.3 munitsfmg protein (liver) and q.6 munits/mg proteiri: (heart). • 
Nucleoside Inhibition (%) Nucleoside Inhibition (%) 
+ NH 2 group - NH 2 group 
Liver Heart Li1.1cr Heart 
Adenosine i9·Z 82.1 Inosine o.z 3-3 
Dcoxyadcnosinc zs.r 2i.O 
Guanosine rS.z I.6 :Xanthosine 7·' S.g 
Cytidine 24-4 4·9 Uridine 9·4 0.0 
Th:ymidine ro.g s .• 
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in a hea.:..-t mitochondrial sonicate. From the A_,_'"Thenius plot [ reciproke value of absolute 
temperature versus log(activity), cf. ref. rg] a Q10 of about 3 could be calculated 
(Fig. 3, insert). Table I shows the data obtained with different preparations using 
two different assay systems to esti."l'Uate long-chain fatty acid activation. This Table 
also gives the energy· of activation for paL'Tlitoyl-CoA synthetase as calculated from 
the Arrhenius plots. Similar results were obtained with liver mitochondria (not sho\.\171). 
The specificity of adenosine as an inhibitor of palmitoyl-CoA synthetase 
In a prelininary note1 the inhibition of palmitoyl-CoA synthetase in heart 
mitochond..--ia by adenosine and some analogs was shown. Table II shows the activity 
of the enzyme in sonicates of liver and heart mitoci1ondriz. in the presence of several 
nucleosides. From tPis Table it can be concluded that the L"lhibition by adenosine is 
somewhat more specific in helli-t than in liver. In liver mitochondria the inhibition 
of the enzyme by the analogs tested seems to be deper..dent on the presence of an 
am.mogroup. 
P ANDE AND MEAD1z reported the inhibition of paLrr:itoyl-CoA synthetase in rat 
liver microsomes by AMP (and to a smaller extent by ADP and cyclic AMP). They 
mentioned 3..1."1 A~IP inhibiti-on of pa.lrn.itate activation by the mitochondrial fraction 
without giving details. In Table HI the inhibition of pal.Tilitoyl-CoA synthetase in 
heart and liver mitochondrial sonicates by a variety of phosphate esters of adenosine 
is shown. As can be seen from Table EI the L.1.tibition by adenosine is several times 
greater- than that obtained by the nucleotides. Adenosinesulfate is as effective an 
inhibitor as adeDosine. This compound could be useful in the study of the regulation 
of palmitate catabolism. 
TABLE lii 
1:-JHIBlTIO:-< OF PALMITOYL-(o.'\ SYNTHETASE IN SOKICATED LIVER A:><D HEART ~HTOCHONDRIA BY 
.'I.DENOSl):fE, ADE):f0SIKEPHOSPHATE ESTERS AND ADENOSINESULFATE 
Conditions were similar to those described in the legend to Table II. 
1 nhibitor Inhibition(~~) 
(2.0 mAl) 
Liver Heart 
_\denosine i9-2 Sz.1 
5~-_\DP 10.5 s.s 
Cyclic 3'.5'-AMP 1:2.4 XJ.5 
Cyclic 2',3'-A:'>IP S.6 7-i 
s'-.\~IP :22.8 24.:2 
3' -A:\11? 19-3 J.O 
2'-.\~lP 9·4 S.6 
.\dcnosine sulfate ;S.4 S3.o 
Only adenosine and adenosinesulfate are able to inhibit oxygen consumption 
and co:! production clearly when palmitate is oxidized by heart or liver mitochondria. 
Details are given in the next paragraph. 
Effects of adenosine and Nagarse on mitochondrial pal1nitate oxidation 
In previous experiments conducted with the Clark oxygen electrode with rat 
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heart mitochondria it was often noted that ADP inhibited palmitate oxidation. A 
typical tracing is shown in Fig. 4- We e>q>ected to find a stimulation by ADP, like 
we observed with substrates like palmitoylcarnitine and pyruvate (see Fig. 4), 
because of the transition of the mitochondria from State 4 to State 3- WARSHAw AND 
TERRY20 showed (in their Fig. 5) that palmitate oxidation in calf heart mitochondria 
was impaired by ADP addition, without discussing the effect. 
Addition of AMP or adenosine, breakdown products of ADP, also inhibited 
palmitate oxidation. This led us to think that adenosine as it could be generated from 
ADP or AMP, might be responsible for the inhibition. The effects, however, were quite 
variable in the short-lasting experiments with the oxygen electrode. Therefore, we 
TABLE IV 
INFLUE~CE OF ADENOSINE AND SOME ANALOGS ON PALMITATE OXIDATION IN HEART MITOCHONDRIA 
Heart mitochondria were isolated as described under Preparations. Oxygen uptake was measured 
with a differential respirometer at 25.0°. Reaction vessels contained 0.25 mM [r-14C]palmitate 
(0.040 pCjp.mole)jo.o4 mM albumin, 1.0 mM L-malate, 2.5 mM ATP, 2.5 mM L-carnitine, o.r mM 
CoASH, ro mM potassium phosphate (pH 7.4), s-o mM MgCl2 , 30 mM KCl, r.r mM EDTA, 
75 mJ.\1 Tris-HCI buffer (pH 7.4), about 2.8 mg mitochondria! protein and 25 mM sucrose. Adeno-
sine and analogs were tested in a final concentration of 2.0 mM. The reaction volume was LO mL 
All constituents were added from stock solutions, if necessary neutralized with KOH. The centre 
well of the vessels was provided with 0.05 ml 2.5 N KOH and a filter paper. The side ann of 
the flasks contained 0.05 ml 70% HC104 . The reaction was started with the mitochondria. 
Readings were taken at 2.5 min intervals. After 30 min the reaction was terminated by additio:r; 
of HCI04 • Shaking was continued for 3o-6o min. The KOH-soaked paper in the centre well was 
transferred with 10 ml scintillation mixture to a counting vial. For details of the measurement 
of 14C02 see ft,[ethods. Total 0 2 consumption was calculated by extrapolation. 
Condition 
Palmitate/albumin omitted 
Palmitate albumin 
+adenosine 
+ deoxyadenosine 
+inosine 
+guanosine 
+ xanthosine 
+ 5'-AMP 
+ 5'-IMP 
+ adenosinesulfate 
+adenine 
+ hypoxanthine 
Total 0 2 uptake (.E p,lfmg protein) 
Expt. I 
20 
42 
4l 
44 
47 
42 
IS 
42 
Expt. II 
IO 
49 
23 
46 
49 
ZI 
14CO 2 production (disint.jmin per mg protein) 
Expt. I 
2362 
2150 
2328 
2871 
2195 
441 
2160 
Expt.II 
2548 
72! 
2535 
2466 
6or 
2475 
Fig. 5· The effect of Nagarse on [1-14C]palmitate oxidation in heart mitochondria (A) and liver 
mitochondria (B). {A) 2.7 mg heart mitochondrial protein was present; further conditions were 
as indicated in the legend to Table IV. In experiment (B) 3-3 mg liver mitochondrial protein 
was used. The palmitate oxidation was stimulated in this case by the addition of 25 mM D-glucose 
and 3 I.U. dialyzed hexokinase {EC 2.7.I.1) (cj. ref. x). 25 ruM potassium phosphate (pH 7-4L 
20 mM KCI, 6o mM Tris-HCl buffer (pH 7 .4) were included in the medium. The reaction was 
started by the addition of mitochondria. Other conditions for liver were identical to those given 
in the legend to Table IV. Where indicated in (A) and (B) Nagarse (0.5 mg) or [r-1-lC]palmitate 
were present from the start or added after preincubation. The reactions were stopped after 30 min 
(heart) or 40 min (liver) and 14C02 was counted (see Table IV). The amounts of 14C0 2 present at 
the end of the e.xperiment are indicated in (A) and (B). dpm = di.3int.jrnin. 
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turned to ma.l.ometry, which enabled us to use radioactive labelled palmitate to 
differentiate between endogenous and added substrate. Table IV shows the oxidation 
of [r-HCJpalmitate by heart mitochondria. In the medium o.r mM coenzyme A is 
included., because it is found that coenzyme A is easily washed out from the mitochon-
dria. I..,ea1:age of coenzyme A !rom rat liver mitochond..""ia is demonstrated by SKREDE 
AKD BREMER.r:o. Several compounds are tried for their ability to inhibit pahnitate 
oxidation. When tested in a concentration of z.o mM only adenosine or aCienosi."le-
sulfate are inhibiror:r to a signLicant extent. The sa..'ITI.e compou..."lds are powerful 
inhibitors of pa1.'Tlitoyl-CoA synthetase (Tables II and III). The discrepancy of oxygen 
uptake and HC0 2 production as fa: as the degree of inhibition is concerned, is probahl.y 
d.ue to the oxidation of endogenous substrates· (mai"lly fatty acids). For ilJStance 
lauroyl-CoA syuthetase (personal communication of H. R. ScHOLTE) anci octanoyl-
CoA s:yuthetase (unpublished observation) are relatively insensitive to the inhibitors. 
When instead o:f heart mitochondria liver mitochondria were tested the inhibition of 
pahnitate oxidation was found to be less. In those experiments (not shown) adenosine 
and ad61osinesulfate inhibited oxygen upta..l.;:e and aco:: production only half as 
strong. In those experiments the conditions used were not the same. In the experi-
ments with heart mitochondria phosphate acceptor was generated, from the 2.5 mM 
ATP present. by Mg2+-sti..."llulated ATPase. In the experiments vvith liver mitochondria 
phosphate acceptor was generated by the addition of hexokinase and glucose. The 
conditions used for palmitate oxidation by liver mitochondria are given in the legend 
to Fig. 5· It should be emphasized that in this case the ATP concentration in the vessels 
is very low, contrary to the experiments conducted with hea..-t mitochondria. Wher1 
it is kept in mind that the h'lhibition by adenosine of palmitoyl-CoA synthetase is 
competitive with respect to ATP (Figs. I and z)_. one could argue that cardiac palmitate 
oxidation is even more sensitive to adenosh'le than hepatic pa1'11itate oxidation. It is 
quite difficult to oxidize palmitate under identical conditions as was shown befor&-. 
In an earlier publication :it was demonstrated that in mitochondria isolated 
from homogenates of liver and heart treated with Nagarse palmitoyl-CoA synthetase 
activity was almost completely lost:::. PaL."llitate oxidation was severely impaired in 
the case of Nagarse-treated heart mitochondria as was shown by DE JoKG AND 
HULSMAN),T1 . The effect of Nagarse on isolated roitochondria was studied in greater 
detaiL Addition of quite large amounts of Nagarse to heart mitochondria oxidizing 
palmitate, failed to produce 'the expected inhibition. If. however, the fatty acid is 
added after Nagarse no palmitate can be oxidized (Fig. 5). Apparently Nagarse is 
not able to destroy the palrnitoyl-CoA synthetase in heart mitochondria when 
conditions are favorable for fatty acid activation, suggesting a change in conformation. 
This was confirmed by experiments (not shown) in which sonicates were preincubated 
with N agarse in the presence of palmitate, ATP and coenzyme A. Palmitoyl-CoA 
synthetase was found to be quite insensitive to the Nagarse action under this condi-
tion. Preincubation with either palmitate, ATP or coenzy"'l1.e A was much less effective 
to protect the enzyme. Also palmitoyl-CoA ( o.z ,uM) was not able to protect the pal-
mitoyl-CoA synthetase from N agarse digestion. Under the conditions specified in Fig. 
5, palmitate oxidation by liver mitochondria is much less sensitive to preincubation 
with Nagarse. The palmitoyl-CoA synthetase present in the outer membrane, is de-
stroyed, but the inner membrane enzyme (insensitive to Nagarse treatmentt), is 
able to provide adequate amounts of palmitoyl-CoA'. 
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CONCLUSIONS 
The effects of Nagarse, hexokinase, adenosine and carnitine on palmitate 
activation and oxidation in liver and heart mitochondria are summarized :in Table V. 
We conclude that :in the oxidation experiments with liver mitochondria, as shown :in 
this communication and in the prelim:inary note1 , palmitate is activated mainly in 
the inner membrane matrix compartment. BEATTIE21 found that 95% of the total 
palmitate oxidation activity (measured as formazan formed from tetrazolium salt) 
of rat liver mitochondria was recovered in the inner membrane matrix fraction, 
as obtained by digitonin treatment. LIPPEL AND BEATTIE7 concluded from this experi-
ment that palmitoyl-CoA SJ!Ilthetase was localized in the inner membrane fraction. 
This conclusion does not seem justified since the preparation contained approx. II% 
outer membrane21, which has a very high palmitoyl-CoA synthetase activity1•·1-&,S, 22• 
VAN ToL AND HuLSMANN4 showed that during hepatic fatty acid oxidation at low 
concentrations of palmitate (i.e. below 40 ,uM), with carnitine present, the outer 
membrane acyl-CoA synthetase is operative. 
TABLE V 
SUMMARY OF THE EFFECTS OF NAGARSE, HEXOKINASE, ADENOSINE AND CARNITINE ON LIVER AND 
HEART MITOCHONDRIAL PALMITATE ACTIVATION A~D OXIDATIOK 
The results were compiled from experiments shown in Figs. I. 2 and 5, Table IV and the prelimi-
nary note1 (Table I). 
Palmitate oxidation Palmitate activation 
Liver Heart Liver Heart 
Inner membrane Outer membrane 
matrix 
Nagarse No effect Inhibition No effect Inhibition Inhibition 
Hexokinase Stimulation Inhibition No effect Inhibition Inhibition 
Adenosine Small inhibition Inhibition Small inhibition Inhibition Inhibition 
Carnitine No effect Obligate 
In heart mitochondria we find only evidence for a palmitoyl-CoA synthetase 
located on the outside of the outer membrane (see also the preliminary note1 ). 
Adenosine is a potent vasodilator as has been shovvn a long time ago by DRURY 
AND SzEN"C-GYORGYI23 (cf. also ref. 24). Many workers reported the formation of adeno-
sine in the heart by breakdown of adenine nucleotides under hy-poxic conditions 
(see, for instance, refs. 25 and z6). KATORI AND BERNE27 emphasized the importance 
of adenosine as the possible metabolite responsible for autoregulation of coronary 
blood flow. It is possible that adenos~"1e reduces mitochondrial palmitoyl-CoA 
formation, when the cardiac oxygen level is low, so that adenosine not only functions 
as a regulator of blood flow contributing to oxygenation and lactate removal, but 
also as a metabolic inhibitor. 
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